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One of the growing public health concerns in the 21st century is the increasing 
prevalence of bacteria that are resistant to antibiotics. This has been due to the overuse 
and misuse of antibiotics in healthcare and agriculture. Increased levels of antibiotic 
resistant bacteria have been observed and new antibiotic-resistant strains of bacteria will 
continue to arise. 
Bacterial resistance to antimicrobials is typically gained through the acquisition of 
genes that confer antibiotic resistance. Such genes are often associated with mobile 
genetic elements (MGEs) such as plasmids and transposons and are capable of moving 
between different bacteria both within a species and in between different species. 
In order to attempt to curb the spread of antimicrobial resistance a greater 
understanding of the effect of antibiotics on both commensal and pathogenic strains of 
bacteria is required, including the investigation into the genetic basis of antibiotic 
resistance. 
The presence of mobile genetic elements was investigated in bacteria that were 
obtained from swabs from infected wounds and saliva from healthy volunteers. These 
isolates were predominantly members of the Streptococcus and Staphylococcus genus. 
Two isolates from wound sites confirmed to be Corynebacterium striatum demonstrated 
resistance to tetracycline (MIC >512ug/ml). Further investigation has revealed that the 
resistance gene present is tetW. A ribosomal protection protein that has only been 
observed once before in this species of bacteria in China. To date there have been no 
such observations in the EU or US. This suggests that the Corynebacterium striatum 
isolates acquired the tetW gene via a plasmid obtained by horizontal gene transfer. 
Sequence analysis of the DNA regions flanking this gene indicate that it may be located 
upon a transposon that belongs to the Tn5253 family. 
The presence of novel plasmids in metagenomic DNA from saliva was 
investigated using transposon aided capture (TRACA), the plasmids that were 
discovered mostly belonged to the pTRACA42 family, plasmids were found that carried 
antibiotic resistance genes that confer resistance to chloramphenicol, ampicillin and 
kanamycin, clonal resistance was confirmed via minimum inhibitory concentration (MIC) 
testing. In order to detect the transposon Tn916, a screening method based upon the 
characterisation of the digestion profile of two polymerase chain reaction (PCR) 
amplicons with the restriction enzyme HincII. This method was used to successfully 
detect Tn916 in the control strain Bacillus subtilus 34A. 
Overall, the data generated throughout this study adds to the body of evidence 
supporting that there is a large reservoir of antibiotic resistance genes that are located 
upon mobile elements, in particular those that belong to the Tn916 family play a 
significant role in the maintenance of tetracycline and erythromycin resistance genes. 
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Chapter 1
Introduction
1.1 Antibiotic Resistance
Antibiotics refer to substances that either kill (bactericidal) or inhibit the
growth of bacteria (bacteriostatic) (Memeth et al., 2014). The discovery and
subsequent clinical application of antibiotics has resulted in a major improve-
ment in infectious disease treatment. However, the continuous exposure to
antibiotics has provided a selection pressure that has facilitated an acceler-
ation in the emergence of antibiotic resistance, particularly in the case of
pathogens that cause nosocomial infections (Hsueh et al., 2002).
The continued emergence of strains of pathogenic bacteria that are resis-
tant to antimicrobial therapies is a significant problem in public healthcare.
Historically bacterial infections, with pathogens such as Staphylococcus au-
reus, were difficult to treat and were potentially fatal prior to the discovery
of penicillin (Flemming, 1929). The introduction of penicillin and subse-
quent antibiotics revolutionised the treatment of bacterial infections. Since
the emergence of antimicrobial resistance the effect of antibiotics as clinical
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treatment has been reduced. Examples illustrating this include the case of a
33 year old woman who was dying as a result of Streptococcal sepsis in 1942,
at the beginning of the antibiotic era whereby treatment resulted in a full
recovery and the patient surviving until age 90. In the space of 66 years and
the rise of antimicrobial resistance saw a different outcome for man who was
aﬄicted with endocarditis as a result of infection by Enterococcus faecium,
antimicrobial treatment failed due to resistance that the infecting strain had
acquired and as such the clinicians were unable to treat his infection using
antibiotics and he subsequently died as a result of the infection (Arias and
Murray, 2009). Such cases demonstrate how, for patients who are infected
with multidrug resistant bacteria, treatment is similar to that in the pre-
antibiotic era.
The evolution of methicillin resistant Staphylococcus aureus(MRSA) shows
the adaption of an organism into a multi-drug resistant pathogen. Shortly
after the introduction of penicillin and other β-lactam antibiotics, S. aureus
developed resistance to β-lactams, by the year 2003 half of the S. aureus iso-
lates recovered from U.S. hospitals were resistant to methicillin (Arias and
Murray, 2009).
The problems that are presented by antibiotic resistance are wider reach-
ing than just the curing of bacterial diseases, antibiotics are crucial in en-
abling the application of medical and surgical techniques to patients who are
weak, elderly or immunocompromised, therefore the increase in antimicrobial
resistance in pathogenic bacteria also impacts medical surgery, anticancer
chemotherapy and patient immunosuppression following transplant (Levy,
1998; Smith et al., 2004). A statement from the World Health Organisation
highlights the severity of antimicrobial resistance: medical procedures once
taken for granted could be conceivably consigned to medical limbo. The
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repercussions of which are almost unimaginable (World, 2000). Therefore it
is necessary to conduct research that addresses means that may aid in the
facilitation of predicting and possibly limiting antibiotic resistance (Martinez
et al., 2007). In order to achieve this, two distinct problems need to be ad-
dressed, these are the acquisition of antibiotic resistance genes by previously
susceptible bacteria (Davies, 1997; Martinez and Baquero, 2000) and intrinsic
resistance (Fajardo et al., 2008).
1.1.1 The Resistome
The concept of the resistome refers to an aggregate of all the antibiotic re-
sistance mechanisms (Wright, 2007; D’Costa et al., 2007). These mecha-
nisms are not confined to the pathogenic bacteria rather they also include
the microorganisms that are not typically associated with disease, an exam-
ple being bacteria that produce antibiotics where the co-evolution of resis-
tance is required in order to prevent auto-toxicity. Previous research has
shown that in multiple occasions the antimicrobial resistance mechanisms
that emerge clinically have originated from non-pathogenic bacteria (Thaker
and Spanogiannopoulos, 2010). Examples of this include glycopeptide re-
sistance due to altered cell wall biosynthesis (Marshall et al., 1998), inacti-
vating enzymes causing aminoglycoside resistance (Davis and Wright, 1997)
and the CTX class of β-lactamases that confer β-lactam resistance (Can-
ton and Coque, 2006) as well as ribosomal methylation (Liou et al., 2006).
The understanding of antimicrobial resistance in its totality rather than the
focusing on mechanisms only from pathogenic bacteria that have emerged
as clinical problems it is possible to better understand the evolution of re-
sistance allowing for the anticipation of new resistance mechanisms coming
from the environment into the clinic and use this information to guide drug
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discovery research (Thaker and Spanogiannopoulos, 2010).
1.1.1.1 The Tetracycline Resistome
The tetracycline resistome is large and diverse, it includes over 1000, re-
ported resistance genes that span over 80 genera and 350 species, this re-
sistome may be the largest against a single class of antibiotics (Thaker and
Spanogiannopoulos, 2010). The reason that there may be such a large dis-
tribution of tetracycline resistance genes may be due to there being a large
amount of naturally occurring tetracycline like molecules in the environment.
It has been estimated that 1 out of 1000 actinomycetes produces tetracycline
(Baltz, 2007). An average soil sample contains approximately 106 - 108 bac-
teria. Tetracycline resistance has been demonstrated in a diverse range of soil
sample from across the globe (D’costa et al., 2006). One theory (Baltz, 2007)
explaining the prevalence of tetracycline resistance is that the 1:1000 acti-
nomycetes produces tetracycline and approximately 5%-6% of the bacteria
that reside within the soil are actinobacteria thus there is a large amount of
naturally occurring tetracycline molecules creating an evolutionary selective
pressure favouring the development and acquisition of tetracycline resistance
(Thaker and Spanogiannopoulos, 2010).
1.2 Nosocomial Infections
Nosocomial infections refer to infections that have been acquired either in
a hospital setting or as a result of healthcare related interventions. For an
infection to be classed as nosocomial, they must arise between 48 and 72
hours following hospital admission or within thirty days following discharge
(Breathnach, 2009). The highest frequency of nosocomial infections in British
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hospitals occurs within intensive care units and surgical wards (Majumdar
and Padiglione, 2012). Antibiotic resistant nosocomial infections are associ-
ated with an increase in the morbidity and mortality of patients (Woodford
and Livermore, 2009).
1.3 Mechanisms of Antibiotic Resistance
1.3.1 The Ancient Resistome
The development of resistance to antibiotics is the product of evolution over
billions of years (Blair et al., 2014). Evidence of this stems from observ-
ing bacteria that reside at pristine sites where there has been no human
activity, yet antibiotic resistance persists (Bhullar et al., 2012). The major-
ity of antibiotics that are employed for use as medication are derived from
antimicrobial compounds that are produced naturally by microorganisms.
As these microorganisms produce antimicrobial compounds, other micro-
bial species that reside in close proximity are exposed to these compounds,
therefore creating a selection pressure for the development and maintenance
of antimicrobial resistance in a setting unrelated to human activity (Blair
et al., 2014). The result of this, is a situation where a natural reservoir of
antimicrobial resistance genes that have the potential to transfer into hu-
man pathogens and thereby reduce the effect of treatment (Wellington et al.,
2013). Since their discovery, the excessive usage of antibiotics by humans in
the fields of medicine and agriculture has provided a selective pressure on
genes that confer resistance to transfer from these ancient resistomes such as
the “soil resistome” into pathogenic bacteria, this is demonstrated by the fact
that the same resistance genes are present in both soil microflora and human
pathogens (Blair et al., 2014). Further evidence supporting this is demon-
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strated by genes that confer resistance to antimicrobials prior to their first
clinical use, for example the recently licensed daptomycin (D’Costa et al.,
2012; Perry and Wright, 2013).
1.3.2 Obstruction of Target
1.3.2.1 Decreased Permeability
An obvious strategy in the development of antimicrobial resistance is to
prevent antimicrobial agents from reaching their target. There are a va-
riety of ways that this can be achieved, one such way is reduced perme-
ability. This is evidenced when comparing Gram positive and Gram nega-
tive species. The reduced permeability of Gram negative bacteria, as a re-
sult of the outer membrane grants these species intrinsic resistance to some
antibiotics, with a notable example being penicillin (Kojima and Nikaido,
2013; Vargiu and Nikaido, 2012). Some species of bacteria, such as Enter-
obacteriaceae,Pseudomonas spp. and Acinetobacter spp. are able to reduce
their permeability via the down regulation or replacement of porins. It has
been noted in recent studies that porin expression reductions have allowed
these species to demonstrate resistance to later generation antibiotics such
as cephalosporins and carbepenems, resistance to these antibiotics typically
occurs via enzymatic degradation (Lavigne et al., 2013). An example of this
has been observed in Enterobacteriaceae where in the absence of carbapenem,
mutations reducing porin production have resulted in the development of
clinically relevant levels of resistance to carbapenem (Poulou et al., 2013).
Exposure to carbepenems creates a selection pressure that favours such mu-
tations in genes that encode porins or are involved with porin expression,
this has been demonstrated by an accumulation of mutations in such genes
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following carbepenem exposure in E. coli and Enterobacter spp. (Tangden
et al., 2013).
1.3.2.2 Eﬄux Pumps
Eﬄux pumps are responsible for the active transportation of antibiotics out
of the cell. Some types of eﬄux pumps are specific and are only able to
remove a certain type of antibiotic, whereas other eﬄux plumps are able
to remove a range of structurally dissimilar antibiotics from the cell, such
pumps are referred to as multidrug resistance (MDR) eﬄux pumps (Blair
et al., 2014).
Eﬄux pumps that transport multiple substrates have not evolved in response
to selection pressure bought about by the antibiotic era (Webber and Pid-
dock, 2001). All bacterial chromosomes contain multiple genes that encode
multi-substrate eﬄux pumps which highlights their ancient origin (Webber
and Piddock, 2001).
1.3.3 Modification of Antimicrobial Targets
1.3.3.1 Structural Changes Based upon Mutation
Antibiotics typically have a high affinity for their target, therefore preventing
the normal activity of the target once bound. Because of this, mutations that
alter the structure of the target may still allow the target to function correctly
yet prevent binding by the antibiotics. Strains that are carrying this mutation
are then able to proliferate, the presence of the antibiotic causes a selection
pressure that encourages the proliferation of strains containing the mutation.
An example of this occurring has been observed from clinical usage of the
antibiotic linezolid, that targets the 23S rRNA of Gram positive bacteria,
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has created a selection pressure favouring a mutant allele in S. pneumoniae
and S. aureus as possession of this allele confers resistance (Gao et al., 2010;
Leclercq, 2002).
1.3.3.2 Direct Modification of Targets
Another mechanism of antibiotic resistance involves the modification of the
target without relying on mutation (Blair et al., 2014). This mechanism is
relevant in the case of several antibiotics, with two examples being tetra-
cycline and erythromycin. Prominent examples include, in the case of ery-
thromycin, the erm family of genes which confer resistance by methylating
the 16S rRNA which prevents erythromycin from binding to its target site
(Blair et al., 2014). In the case of tetracycline, the gene tetM provides protec-
tion to the ribosome by encoding a soluble protein that prevents tetracycline
from binding to the ribosome, as such TetM belongs to a family of proteins
called ribosomal protection proteins (RPPs) (Donhofer et al., 2012). Orig-
inal models describing the mechanism by which TetM prevents tetracycline
from binding to the ribosome described an indirect situation where the TetM
protein prevents tetracycline binding by causing conformational changes to
the structure of the ribosome. Since then, an alternative model has been
presented where TetM directly dislodges tetracycline from its binding site on
the ribosome to confer resistance (Donhofer et al., 2012).
1.3.4 Modification of Antimicrobial Agents
Some mechanisms of antibiotic resistance rely upon the direct modification
of antimicrobial agents to render them ineffective. This was the first mech-
anism of antimicrobial resistance discovered in 1940 with the discovery of
β-lactamase (Blair et al., 2014). There have been thousands of enzymes
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identified that confer resistance to antimicrobial agents of unrelated classes.
In addition to this there are also subclasses of enzymes that are able to in-
activate antibiotics within the same class. An example can be seen in the
β-lactam antibiotics where different types of β-lactams such as penicillins,
carbepenems, cephalosporins, monobactams and clavams are rendered inef-
fective due to hydrolysis by different β-lactamase enzymes (Voulgari et al.,
2013).
1.3.5 Resistance to Tetracycline Antibiotics
Genes that confer resistance to tetracycline are named as tet genes referring
to tetracycline resistance or otr genes referring to oxytetracycline resistance,
the difference in nomenclature is due to the oxytetracycline resistance genes
being discovered in bacteria that produce oxytetracycline, there is no inherent
difference between tet and otr genes (Chopra and Roberts, 2001).
1.3.5.1 Tetracycline Eﬄux
To date there have been 26 different classes of tetracycline eﬄux pumps
that have been discovered (Thaker and Spanogiannopoulos, 2010), these have
been classified into 11 groups (Chopra and Roberts, 2001; Roberts, 2005).
Eﬄux proteins are found across several microbial genera, and are membrane
proteins that span across the lipid bilayer of the inner cell membrane 12 to
14 times (Thaker and Spanogiannopoulos, 2010).
1.3.5.2 Ribosomal Protection
The RPP represent a class of tetracycline resistance determinants that is
widely distributed spanning both Gram positive and Gram negative species.
There are 11 different types of RPPs with Tet(M) and Tet(O) being the most
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prevalent and heavily studied classes. Tet(M) has been detected within 24
genera and Tet(O) has been detected in 8 genera. There are three groups of
RPPs that have been classified based upon their amino acid sequences, these
groups are shown in Table 1.1. RPPs confer resistance to tetracyclines by
weakening the interaction between tetracycline and the ribosome resulting
in the subsequent antibiotic release, freeing the ribosome from the inhibitory
effects caused by tetracycline (Connell et al., 2003). This mechanism con-
fers resistance to first and second generation tetracyclines but not the third
generation. For example the third generation tigecycline has been shown
to exhibit antibacterial activity against Tet(M)-protected ribosomes possi-
bly because the drug has a stronger binding to its target (Rasmussen et al.,
1994).
Table 1.1: RPP class of tetracycline resistance determinants further categorised
into three groups based upon amino acid sequence (Thaker and Spanogiannopou-
los, 2010)
.
Group 1 Group 2 Group 3
Tet(M) TetB(P) Tet(Q)
Tet(O) Otr(A) Tet(T)
Tet(S) Tet
Tet(W)
Tet(32)
Tet(36)
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1.3.5.3 Enzymatic Inactivation
There have been relatively few tetracycline inactivators that have been re-
ported, this is in contrast to other classes of antibiotics such as aminogly-
cosides and β-lactams where modification and inactivation are the predom-
inant mechanisms of resistance, as of 2010 only three such genes had been
identified within the tetracycline resistome (Thaker and Spanogiannopoulos,
2010) however 10 more such genes have been discovered since then. The first
tetracycline resistance determinant that confers resistance to tetracycline via
this mechanism was discovered in 1989 was Tet(X) from Bacteroides fragilis
(Speer and Salyers, 1989).
1.3.5.4 Mosaic Elements
Mosaic derivatives of known tetracycline resistance genes have recently been
discovered, in mosaic genes at least one section of the gene shows a homology
that is above 80% to a known tetracycline resistance gene and the other
section shows homology to either a different known tetracycline resistance
gene or a new determinant (Thaker and Spanogiannopoulos, 2010). These
mosaic elements are composed of determinants from the RPP group and have
involved Tet(M), Tet(O), Tet(W) and Tet(32). Most of the bacteria that
have been found carrying mosaic elements have been isolated from either
farm animals or humans. All of the mosaic genes that have been identified
to date have shown different patterns of mosaicism however the final size of
the gene remains unaltered (Thaker and Spanogiannopoulos, 2010).
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1.4 Horizontal Gene Transfer
Horizontal gene transfer (HGT) refers to the transfer of genetic material be-
tween bacteria without reproduction as in vertical gene transfer (Poole, 2009).
HGT is an important mechanism in the dissemination of antibiotic resistance
genes. HGT occurs via three different mechanisms. The three main mech-
anisms facilitating HGT are conjugation, transformation and transduction.
Conjugation refers to the direct transfer between donor and recipient cells
in a manner that is insensitive to DNase enzymes, this mechanism facilitates
the transfer of conjugative plasmids and conjugative transposons (Roberts
and Kreth, 2015). Transduction refers to the transfer of host genomic DNA
by bacteriophages that package host DNA into the bacteriophage head struc-
tures (Roberts and Kreth, 2015). Whereas transformation refers to the up-
take of exogenous extracellular DNA present in the environment, often this
DNA has been released by dead bacteria (Roberts and Kreth, 2015).
1.5 Mobile Genetic Elements
Mobile genetic elements refer to sections of DNA that are able to move as
a result of genes that code for proteins that facilitate the movement of the
DNA both intra-cellularly (within the same cell, between different parts of the
bacterial genome, and between plasmids and the chromosome), and extra-
cellularly (in between different bacterial cells both belonging to the same
species, and other species of bacteria) (Frost et al., 2005). The transfer of
antibiotic resistance genes in bacteria typically occurs as a result of mobile
genetic elements such as transposons and plasmids. Such mobile elements
have the capability of moving between different bacteria both within the
same species and in between different species, these elements are responsible
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for increased levels of antibiotic resistant bacteria in patients who are under-
going antimicrobial therapy (Warburton et al., 2007). In addition to this,
research has resulted in the identification of mobile elements that carry mul-
tiple antibiotic resistance genes that confer resistance to unrelated antibiotics
(Henderson-Begg et al., 2009; Warburton et al., 2007).
1.5.1 Conjugation
Conjugation refers to cell to cell DNA transfer that may occur, sometimes
through a pilus that connects the two cells and acts as a tunnel allowing
genetic material to pass through. Conjugation is also possible via cell to cell
contact without the presence of a pilus. Conjugation usually involves con-
jugative elements that are self transmissible such as plasmids and conjugative
transposons (Frost et al., 2005).
1.6 Plasmids
1.6.1 Overview
Plasmids are DNA molecules that are able to replicate and exist indepen-
dently from the bacterial genome, some exist in a circularised form whereas
others are linear. They are ubiquitous and exist naturally within prokaryotes,
arcehea and eukaryotyes (Meinhardt et al., 1990; Zillig et al., 1996; Couturier
et al., 1988). They vary in size and may confer selective advantages to their
host bacteria, for example genes that confer resistance to antibiotics or genes
that enable the host bacteria to metabolise nutrients more effectively. When
the host cell divides and the bacterial chromosome is replicated, any plasmids
that are present within the bacteria are also replicated. These elements are
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able to transfer between different bacterial cells via the process of conjugation
(Arias and Murray, 2009).
1.6.2 Plasmid Types
1.6.2.1 Linear Plasmids
Linear plasmids have been discovered in both Gram positive and Gram neg-
ative bacterial species (Hinnebusch and K., 1993), they were first discovered
in Streptomyces sp. in 1979 (Hayakawa et al., 1979). Research has uncov-
ered linear plasmids in the tick born spirochaete pathogen Borrelia turicatae
(Kingry et al., 2016) The linear plasmids of Borrelia have a covalently closed
hairpin loop at each end, whereas the linear plasmids found in Streptomyces
sp. have a covalently attached protein at each end (Hinnebusch and K.,
1993).
1.6.2.2 Conjugative Plasmids
Conjugative plasmids are plasmids that are able to initiate and use bacterial
conjugation in order to transfer between different cells (Norvick et al., 1976).
Bacterial conjugation refers to the process whereby genetic information is
exchanged between a donor and recipient bacterial cell via cellular contact
(Norvick et al., 1976). Conjugative plasmids are large compared with non-
conjugative plasmids, conjugative plasmids greater than 100kb exist. This
larger size reflects the DNA that they carry that is required to encode the
proteins that are involved with conjugation, this DNA can be around 20-30kb
in size (Bennett, 2008). Different conjugative plasmids exhibit either a broad
or narrow range in their host bacteria with both types being common, an
example of a plasmid with a broad host range is RP1 which was first detected
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in Pseudomonas aeruiginosa, this plasmid is able to transfer to most Gram
negative species (Bennett, 2008).
1.6.2.3 Nonconjugative Plasmids
These plasmids lack the necessary genes to be able to initiate bacterial conju-
gation in order to facilitate transfer, however, some nonconjugative plasmids
may mobilise via conjugative factors that co-exist within the host cell, these
are known as mobilisable plasmids (Norvick et al., 1976). Nonconjugative
plasmids are typically smaller than conjugative plasmids, often smaller than
10kb, these plasmids lack the necessary genes that are required to initiate
conjugation, however they do carry genes that facilitate the transfer of their
own DNA as these plasmids are mobilisable when they are co-resident with
a conjugative plasmid that is able to initiate conjugation (Bennett, 2008).
1.6.3 Plasmid Incompatibility
Plasmid incompatibility occurs when two plasmids that are present within
the same bacterial host cell are not able to both be successfully inherited by
the daughter cells resulting in the two plasmids being inherited by different
daughter cells. Incompatibility arises as plasmids that have the same origin
of replication systems, cannot co-exist within the same cell (Norvick et al.,
1976). Plasmids that are not compatible with one another have been placed
into “incompatibility groups” as a means of plasmid classification, of which
over 30 of such groups exist presently (Shintani et al., 2015).
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1.7 Maintenance and Stability Systems
While the advantages of HGT are clear, it is still not sufficient alone to
understand how plasmids are able to persist over a long period of time in
bacterial populations (Millan et al., 2016). Classical models predict that
HGT via conjugation is required in order to maintain the plasmid population
due to the fitness cost that is associated with carrying plasmids (Vogwill and
MacLean, 2014; Baltrus, 2013). More recent research show that there is
a compensatory adoption that alleviates plasmid fitness cost which allows
plasmids to persist within a population for hundreds of generations without
the necessity of HGT (Harrison and Brockhurst, 2012; Peria-Miller et al.,
2015). It is also possible for beneficial genes that have originated on plasmids
to transfer to the bacterial chromosome via transposons which allows the
bacteria to keep the benefits that are associated with a particular gene whilst
eliminating the fitness cost from the plasmid (Modi et al., 1992). Although
this is the case, it has been demonstrated that there are advantages to carry
a gene on a plasmid rather than the bacterial chromosome, one advantage
is that if the gene is being carried on a multi copy plasmid then higher
gene expression will be produced (Latorre et al., 2005), another possible
advantage is the variation in plasmid copy number in the different cells of
the population causing gene expression heterogeneity which may provide a
beneficial phenotypic plasticity (Zhang et al., 2009). Another advantage to
carrying genes on plasmids that was recently demonstrated is that multicopy
plasmids function as platforms for evolution via increasing the mutation rate
because of the increased gene copy per cell (Millan et al., 2016).
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1.7.1 Toxin-Antitoxin Systems
Toxin-Antitoxin (TA) systems refer to a pair of complimentary gene codes,
one of which codes for a toxin and the other codes for an antitoxin. The TA
genes are located upon plasmids and collectively create an environment in
which for the bacteria to survive it is essential for the plasmid to be inherited
when the bacteria divide. This occurs because in the absence of the plasmid,
the unstable antitoxin is no longer coded for and therefore is not replenished,
thus the bacteria continues to live in the presence of the stable toxin even-
tually leading to a form of toxicity, referred to as post-segregational killing
(PSK) (Hayes, 2003). The first TA system to be discovered was ccdA/ccdB,
this module was shown to enhance F plasmid stability by the post segre-
gational killing of plasmid free daughter cells (Unterholzner et al., 2013).
Another role of TA systems is in the exclusion of co-existent compatible
plasmids (Cooper and Heinemann, 2000). During the process of conjuga-
tion, bacterial cells may arise that contain two plasmids that belong to the
same compatibility group, when this occurs the two plasmids can not be sta-
bly maintained within the host. The TA module ensures that the plasmid
that it is located upon is the one that is maintained within the bacterial pop-
ulation, as the loss of the plasmid that contains the TA module will result in
the death of the daughter cell whereas if the cell loses the other plasmid it is
unaffected, following several rounds of conjugation and exclusion, the plas-
mid that contains the TA module is able to out-compete the second plasmid
from the population of host bacteria (Unterholzner et al., 2013).
The toxins of all bacterial TA systems that have been characterised are pro-
teins, whereas the antitoxins can be either proteins or small RNA molecules.
Five categories of TA modules exist (Types I-V). These are classed based
upon their regulation and genetic structure. Type I and type III modules
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have antitoxins that are small noncoding RNA molecules. The type II, IV
and V the antitoxins are modules (Unterholzner et al., 2013).
1.7.1.1 Type I
Type I TA modules have been found on both plasmids and bacterial chromo-
somal DNA (Unterholzner et al., 2013). In type 1 TA modules the antitoxins
are unstable antisense RNA molecules, the expression of the toxin is gener-
ally downregulated by the base pairing of the antitoxin RNA with the stable
toxin mRNA (Brantl, 2012). Downregulation occurs as this interaction pre-
vents the binding of the mRNA to the ribosome therefore inhibiting the
translation of the toxin mRNA (Fozo et al., 2008). The symR/symE module
from E. coli is an example of a type I TA system (Kawano et al., 2007).
In this example, additional regulation over the expression of the toxin symE
exists in the form the SOS-response regulated transcriptional repressor LexA
as well as the protease Lon which degrades SymE LexA is responsible for
SymE synthesis at the level of transcription, SymR RNA represses SymR
synthesis at the mRNA level and Lon represses SymR at the stable protein
level (Ferna´ndez de Henestrosa et al., 2000). Other examples of type I TA
modules include fstI/rnaII on the plasmid pASD1 (Greenfield et al., 2000)
as well as ibs/sib and tisB/istR-1 which are both found upon the E. coli
chromosome (Fozo, 2012)). The type I antitoxin RNA molecules encoded by
plasmids have an extensive complementarity with the toxin mRNA whereas
in many cases the type I antitoxins that are chromosomally encoded act by
base pairing with targets that have limited complementarity (Park et al.,
2013). It has been hypothesised that an extensive complementarity could
limit the dissociation of RNAs although the level of complementarity that is
required for regulation is not known (Fozo et al., 2008).
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1.7.1.2 Type II
In type II TA modules, both the toxin and the antitoxin molecules are pro-
teins. The antitoxin neutralises the toxin via the formation of a protein-
protein complex which is subsequently degraded by the protease Lon (Van Melderen
et al., 1996) or by proteases of the Clp family (Diago-Navarro et al., 2013;
Lehnherr and Yarmolinsky, 1995). In many cases type II TA modules are
composed of an operon that contains two open reading frames, of which the
gene upstream codes for the antitoxin protein (Unterholzner et al., 2013).
There are however exceptions to this, one example being the type II TA
module higB/higA from Vibrio cholerae. In this module the toxin encoding
gene higB is located upstream of the antitoxin encoding gene higA (Tian
et al., 2001). The translation of the type II TA operon is typically regulated
automatically by the binding of either the antitoxin or the antitoxin-complex
to the promoter (Bukowski et al., 2011).
1.7.1.3 Type III
As is the case with type I TA systems, type III system use RNA molecules as
the antitoxin however the mechanism of interaction is different to the RNA
molecules in type I systems (Unterholzner et al., 2013). An example of a type
III TA module is toxI/toxN of plasmid pECA1039 isolated from the bacteria
Pectobacterium carovoum (Blower et al., 2012). This was originally described
as a mechanism that protected bacteria against infection from bacteriophages
(Fineran et al., 2009). In this module the toxN gene is preceded by a tandem
array of direct repeats and a short inverted repeat. The inverted repeat
functions as a terminator in the regulation of the levels of antitoxin RNA
and toxin mRNA (Unterholzner et al., 2013). The toxin protein ToxN has
RNase activity and cleaves the toxI/toxN transcript at the direct repeats
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which releases the active 36 nucleotide antitoxin RNA (Blower et al., 2012).
This interaction between the protein and RNA leads to the formation of a
heterohexameric triangular assembly of three ToxN proteins, these proteins
are interspaced by three 36 nucleotide ToxI RNA pseudoknots (Unterholzner
et al., 2013; Blower et al., 2011) and this binding interaction has a high
molecular specificity (Short et al., 2013).
1.7.1.4 Type IV
In the case of type IV TA systems the toxin and the antitoxin do not directly
interact (Unterholzner et al., 2013). An example of a type IV TA system
is yeeU/yeeV of the bacteria E. coli (Masuda et al., 2012; Unterholzner
et al., 2013). In this system, the toxin YeeV interacts with the proteins
FtsZ and MerB by interfering with their polymerisation and by extension
cytoskeleton assembly. The antitoxin YeeU counteracts the effects of YeeV
via the stabilisation of FtsZ and MreB polymers, thus neutralising the effect
of the toxin indirectly (Unterholzner et al., 2013). The TA module cptA/cptB
also from E. coli is reported to operate according to a similar mechanism
(Masuda et al., 2012).
1.7.1.5 Type V
The TA module ghoS/ghoT from E. coli has been designated as type V.
In this module the GhoS antitoxin protein has endonuclease activity that
is sequence specific for the cleavage of GhoT toxin mRNA which therefore
results in the prevention of GhoT translation (Unterholzner et al., 2013;
Wang et al., 2012).
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1.8 Plasmid Replication
1.8.1 Plasmid Replication Mechanisms
Plasmid replication occurs in a manner that is autonomous and self con-
trolled, however during replication plasmids make extensive use of the host
machinery that is responsible for chromosomal DNA replication (Del Solar
et al., 1998). There are three primary mechanisms that are employed in the
replication process of circular plasmids, these are rolling circle (RC) theta
type replication and strand displacement (Del Solar et al., 1998). Different
mechanisms are involved in the replication of linear plasmids, which repli-
cate by either using concatemeric intermediates or by using a protein priming
mechanism (Salas, 1991). Plasmids contain an essential location that con-
tains the genes that are necessary for replication to take place (Del Solar
et al., 1998). The first of these essential genes is termed ori, and encodes
a protein that is involved in the initiation of replication (Del Solar et al.,
1998). The essential location also contains genes that are involved in the
control of replication. This requirement for plasmid associated initiation
genes is reflected in that there are DNA cognate sites present in the origin
of replication which is where the interaction between DNA and protein takes
place (Del Solar et al., 1998).
1.8.2 Origins of Replication
The origins of replication contain sites that are necessary for interactions with
proteins that are both plasmid encoded and host encoded. The plasmid origin
of replication is the minimal cis-acting region that is able to support the
autonomous replication of the plasmid, i.e. the region where DNA is melted
initiating the process of replication at the location where DNA synthesis of
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the leading strand begins (Del Solar et al., 1998).
1.8.3 Mechanisms of Replication Initiation Regulation
Replication initiation frequency is regulated by negative feedback loop mech-
anisms (Nordstrom, 1994). Such mechanisms allow for rapid expansion when
the plasmids colonise a new compatible cell, known as the establishment
phase. Once the cellular plasmid population has been established, the fre-
quency of plasmid replication decreases so that there is approximately one
replicative event per copy number per cell cycle therefore minimising fluc-
tuations in copy number (Nordstrom, 1994). Regulation of plasmid copy
number relies upon mechanisms to monitor the copy number via a “sensor”
as well as mechanisms that modulate the initiation of replication through
an “effector” (Del Solar and Espinosa, 2000). The sensory mechanism is
dependent upon molecules where concentration in the cytoplasm is propor-
tional to the copy number. In the case of plasmids that replicate via theta
replication, inhibition of replication occurs during the initiation step and is
dependent upon three different mechanisms, these mechanisms are: (i)The
binding of Rep proteins to iterons that are located in the Rep promoter;
antisense RNA molecules that hybridise to a complementary section in an
RNA that is essential for initiation; (iii) steric hindrance between plasmids
via the interaction of Rep proteins that are bound to different plasmids. In
each of the cases described above, the same molecule is responsible for both
the sensor and effector functions (Lilly and Camps, 2015).
1.8.3.1 Inhibition of Countertranscribed RNA
Each of these feedback mechanisms contains the following elements: two
promoters facing opposite directions, one promoter directs RNA synthesis,
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the other directing the synthesis of an inhibitor countertranscribed RNA
(ctRNA). This ctRNA is complementary to a region that is located close to
the 5’ end of the essential RNA. The ctRNA is usually strongly expressed yet
has a short half-life whereas the RNA that it targets is expressed at lower
levels but is constitutive (Hayes, 2003). Examples of this mechanism can be
seen in ColE1 plasmids where ctRNA targets a primer that is required for
replication initiation. Other examples of ctRNA targets include the inhibi-
tion of RepA translation in R1 plasmids, and the premature termination of
an mRNA encoding a Rep protein in class D theta plasmids (Wagner et al.,
2002). Initial contact between the sense and antisense RNAs occurs via the
pairing of complementary sequences at the loop portion of stem loops, this is
a rate limiting step that is known as the “kissing complex formation” (Lilly
and Camps, 2015). There are many ctRNAs that have a short half-life due
to the presence of an RNase E cleavage site which contains a U rich sequence
as well as a hairpin structure at the 3’ end (Hayes, 2003). Cleavage by RNase
E results in the production of monophosphorylated decay intermediates that
lack short portions of the 5’ end (Lilly and Camps, 2015).
1.8.3.2 Single Mechanisms Involving ctRNA
In the plasmid ColE1, the ctRNA (RNAI) is from a promoter (P1) that is lo-
cated 108bp downstream from the sense promoter P2. Three stem loops are
formed from both the primer and the preprimer, the loop is composed of 6 to
7 unpaired residues (Lilly and Camps, 2015). The pairing of these residues
with their counterparts is responsible for the initiation of hybridisation. Fol-
lowing pairing, the 5’ end of RNAI nucleates the hybridisation between the
two RNAs resulting in the formation of a duplex (Lilly and Camps, 2015).
Hybridisation occurs between the ctRNA and the preprimer which leads to
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conformational changes in the preprimer, these changes are mediated by the
interaction of the sequence domain β in the preprimer with the γ sequence
that is located further downstream which results in the preprimer becoming
incompetent for R-loop formation further downstream (Polisky, 1988). As
well as being short lived, RNAI from ColE1 has a short window of action due
to RNA II being transcribed 200 bp downstream of the DNA/RNA switch.
The hybridisation of the β domain with the α domain results in the for-
mation of a new loop making RNAII refractory to the inhibition of RNAI
(Lilly and Camps, 2015). The competitive hybridisation between tRNA and
RNAI/RNAII interferes with RNAI/II hyrbid formation (Lilly and Camps,
2015). In addition the uncharged tRNA is responsible for the cleavage of
RNAI, as well as this the uncharged tRNAs contain a 3’-CAA terminus that
is able to hybridise stably with RNAI (Wang et al., 2002). The functional in-
teraction between RNAI and tRNAs influences the deregulation of the copy
number that is associated with the amino acid starvation of relA strains
that are used in recombinant gene expression (Lilly and Camps, 2015). In
the case of ColE2 plasmids, the ctRNA is also known as RNAI and it has
a secondary complex structure. The RNAI is complementary to the 5’ end
of rep mRNA which contains an untranslated sequence, inhibition in this
case is likely caused by the structural disruption of secondary and tertiary
structures that are required for translation as the 5’ end of RNAI does not
cover the initiation codon of Rep (Hiraga et al., 1994).
1.8.3.3 Dual Mechanisms Involving ctRNA
These are mechanisms that regulate the plasmid copy number using two
elements, these elements include a transcriptional repressor protein and a
ctRNA (Del Solar and Espinosa, 2000). In dual systems, the expression of
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Rep proteins is controlled by a strong, repressor regulated promoter causing
a high rate of Rep transcription when the repressor does not operate (Lilly
and Camps, 2015). Dual mechanism of regulation have been most extensively
studied in the plasmids R1 and pIP501. In the plasmid R1, the ctRNA is
CopA and the repressor is CopB (Cervantes-Rivera et al., 2010). In the case
of the plasmid pIP501 the ctRNA is RNAIII and the repressor is CopR.
Such dual mechanisms may confer an advantage to the plasmids during the
establishment phase, particularly in the case of mobilisable plasmids such
as class D theta plasmids (Sharma et al., 2004). In the case of the plasmid
R1, the protein RepA may be transcribed either from an upstream promoter
P1 or from an alternative promoter located downstream called P2. The
expression of repA is coupled to a small leader peptide called tap (Del Solar
and Espinosa, 2000). CopA inhibits the expression of RepA via the inhibition
of the transcription of tap. CopB is a transcriptional regulator of P2, when
CopB levels are high, tap and RepA are transcribed as polycystron cobB-
tap-RepA RNA from P1, as P2 is silenced by CopB. When CopB levels
are low, the P2 promoter becomes depressed and tap and RepA may also
be expressed from this alternative promoter which results in the transient
increase in the expression of tap and RepA (Malmgren et al., 1996). In class
D theta plasmids there is a cop-ctRNA-rep modular structure (Lilly and
Camps, 2015).
1.8.3.4 Regulation via Rep Binding
In the case of some class A theta plasmids, a mechanism copy number reg-
ulation is dependent upon the inhibition of Rep transcription by Rep itself
(Lilly and Camps, 2015). In such plasmids, iterons are located within the
promoter of the Rep operon outside of ori. Rep binds to these cognate se-
25
quences resulting in the inhibition ore Rep expression therefore acting as an
auto-regulatory mechanism. The binding of Rep to two alternative binding
sites results in changes to the conformational structure of Rep. This mecha-
nism has been studied in detail in the Rep A protein that is associated with
the plasmid pPS10 (Giraldo et al., 2003). This Rep protein is composed of
two winged helix domains named WH1 and WH2. When the Rep A protein
is in dimeric form it acts as a transcription repressor where the WH1 domain
functions as a dimerisation interface (Lilly and Camps, 2015). Low concen-
trations of the protein Rep A are linked to the dissociation of Rep dimers
into monomers, these are the only form that is active as an initiator. The
monomerisation of Rep involves the conversion of the dimerisation domain to
a second sequence binding to ori and the remodelling of the WH1 sequence
causing it to bind to the opposite iteron end (Giraldo et al., 2003). In some
plasmids, the monomerisation of Rep is assisted by chaperone proteins or by
the alliosteric effect of binding iterons at ori (Diaz-Lopez et al., 2003).
1.8.3.5 Steric Hindrance
Steric hindrance is another feedback mechanism that is associated with the
regulation of plasmid copy number, this mechanism was originally proposed
for P1 and RK6 plasmids however they could operate in more iteron contain-
ing plasmids (Gasset-Rosa et al., 2008). In this model, as the copy number
of plasmids per cell increases the Rep proteins that are bound to the iterons
of one ori begin to interact with similar complexes that have formed in other
origins, such pairing is known as handcuffing (Lilly and Camps, 2015). This
pairing produces Rep-Rep interactions which results in steric hindrance to
both oris therefore interfering with the melting of ori (Zzaman and Bas-
tia, 2005). The Rep molecules are paired through the zipping up of DNA
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bound Rep A monomers (Lilly and Camps, 2015). One difference between
this model of copy number regulation and the auto-regulation model is that
replication rate is dependant upon the concentration of iterons as opposed
to the Rep expression level. Both of these mechanisms of regulation could
be working together for initiators that are limiting (Das et al., 2005).
1.8.3.6 Summary
Plasmids contribute to bacterial adaptation to environments that are con-
stantly changing through their mobilisation and amplification of selected
genes (Samalla and Sobercky, 2002). Different plasmids show differences
in duplex melting as well as leading strand priming and the synthesis of the
lagging strand. The maintenance of a stable plasmid copy number is criti-
cal for the host bacteria as the loss of the plasmid results in the loss of the
adaptive functions that are carried upon the plasmid, and runaway plasmid
replication is lethal for the host. As such, mechanisms that regulate plasmid
replication represent potential targets for antimicrobial intervention (Lilly
and Camps, 2015).
1.8.4 Rep Proteins
Rep proteins are responsible for the initiation of replication and are encoded
by the plasmid, however in order to replicate some theta plasmids rely ex-
clusively upon host initiation factors (Giraldo, 2004). The recognition sites
of Rep proteins contain direct repeats known as iterons, of which the specific
sequence and spacing are important for initiator recognition. Rep proteins
are also rate limiting in terms of plasmid copy number, for example con-
trolled expression of Rep proteins pi of R6K and RepA of ColE2 can result in
a variation in the plasmid copy number that ranges between 1 and 250 copies
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(Kittleson et al., 2011). The structure of plasmid replicons is typically mod-
ular, containing motifs that are recognised by plasmid encoded Rep proteins
(Lilly and Camps, 2015).
1.8.5 Plasmids and Antibiotic Resistance
Plasmids mediate the HGT of genes between bacteria therefore having an
important role in driving bacterial evolution (Millan et al., 2016). Bacterial
sexual activity was first observed in E. coli in 1946 (Lederberg and Tatum,
1946) over a decade before antibiotic resistance was first reported. In the
1960s, the transmission of antibiotic resistance genes on large R-plasmids
was observed within Enterobacteriaceae via a contact based mechanism called
conjugation. During the same period an increase in antimicrobial resistance
amongst Gram positive bacteria was also being reported however any such
R-plasmids were not detected until the discovery of a R-plasmid moving via
conjugational transfer was identified in Enterococcus faecalis.
The transfer of plasmids is one mechanism by which bacterial genes are trans-
ferred horizontally. Plasmid mediated transfer is problematic in healthcare
as plasmids are able to transfer between different species, allowing resistance
genes a mechanism to cross species and genus barriers, it has been reported
that the rate of plasmid transfer is increased in heterogeneous environments
(Dionisio et al., 2002). This leads to plasmids being able to spread resistance
genes into niche areas that have had had limited exposure to antibiotics
(Hughes and Datta, 1983). Many plasmids carrying antibiotic resistance
genes are conjugative (Bennett, 2008). Plasmid mediated antibiotic resis-
tance encompasses most of the antibiotic classes that are in use clinically
(Bennett, 2008).
The first plasmids that were isolated prior to the discovery and widespread
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use of antibiotic therapy were commonly found however during this era the
presence of antibiotic resistance genes upon the plasmids was rare. In order to
understand the significance of the resistome that existed in the pre-antibiotic
era there have been retrospective studies analysing samples from around this
time. These studies have demonstrated that antibiotic resistance genes were
present in non-antibiotic producing bacterial strains prior to the widespread
dissemination of antimicrobial agents (Allen et al., 2010). Thirty strains of
E. coli were lyophelized prior to 1950, these were tested for susceptibility
against 8 antibiotics and 4 strains were reported to be resistant, all resis-
tance elements found were able to conjugate into E. coli (Smith and Halls,
1967). Another retrospective study analysing 433 strains of Enterobacteriae
that had been collected from a variety of locations around the world between
1917 and 1952 found that 24% of these strains could transfer plasmids and
furthermore 11 strains were resistant to either tetracycline or ampicillin how-
ever in all cases the resistance was not associated with a conjugative element
(Hughes and Datta, 1983), since then another study has investigated his-
torical Enterobacteriae samples finding similar results (Hount and Ochman,
2000). These studies confirm that antibiotic resistance determinants existed
naturally in the pre-antibiotic era and were likely mobile via horizontal gene
transfer before the dramatic increase in selection pressure favouring the ac-
quisition of antimicrobial resistance determinants was imposed following the
introduction of antibiotic use in therapy (Allen et al., 2010).
Plasmids have frequently evolved to carry antibiotic resistance genes as mo-
bile genetic elements may evolve to provide benefits to the host organism,
this is likely due to the fitness cost that harbouring mobile elements such as
large plasmids has upon the host, plasmids that do not offer an environmen-
tal advantage may be ejected or silenced by degrading mechanisms such as
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methylation or restriction (Rankin et al., 2011).
1.9 Transposons
The definition of a transposon is of a genetic element that is able to change its
position in a DNA segment by moving dependent on excision and integration
reactions. When transposons were first identified, it appeared that they
were simple elements, however further investigation has revealed the presence
of more complicated transposons that are diverse in their structures and
properties (Ochman et al., 2000). In addition to this, the first transposons
discovered were small, being less than 15kb and were only able to change their
position within the same cell in contrast to the larger transposons that are
able to travel between different cells via the process of conjugation (Ochman
et al., 2000). Transposon site selectivity varies between the different elements,
for example the transposon Tn5 and bacteriophage Mu are able to integrate
into a wide range of different sites whereas other transposons are able to
integrate into a more limited number of sites.
The function of transposons varies between different elements. Some trans-
posons are segments of DNA of which their only function is the act of moving
from one place in the cellular DNA to another whereas other transposons
also carry additional genes that confer a fitness advantage for the bacterial
host. The least complicated type of transposable elements are the insertion
sequences (IS), these only carry genes that are necessary for transposition.
Larger more complicated transposons also carry a variety of accessory genes
that can have a range of different functions such as genes that confer resis-
tance to antibiotics or heavy metals, nitrogen fixation genes and genes that
are involved in the synthesis of vitamins (Ochman et al., 2000). Transpos-
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able elements are widely dispersed in nature (Stewart and Costerson, 2001),
this distribution suggests they have contributed to the evolution and diver-
sity of microbial genomes as they facilitate the acquisition of new genes and
promote rearrangements in DNA that are central to the process of evolution
(Hallet and Sherratt, 1997).
1.9.1 Common Themes in Transposition
There are some features that are common to many transposons. The first
step of transposition typically involves the recognition and cleavage of the
transposon ends by a transposase, causing the generation of an active 3’-
OH group. Once the transposon ends have undergone cleavage the activated
3’-OH groups initiate a nucleophilic attack either on the opposite strand in-
tramolecularly causing a hairpin structure to form, or intermolecularly on a
target DNA molecule resulting in the generation of a cointegrate or deletions
(Barabas et al., 2008). This nucleophilic attack may also occur intramolecu-
larly on the other end of the transposon resulting in the formation of a figure
8 structure (Ochman et al., 2000).
1.9.2 Types of Transposition
Four mechanisms of transposition have been discovered, these are conserva-
tive transposition, replicative transposition, excisive transposition and retro-
transposition (Ochman et al., 2000).
1.9.2.1 Conservative Transposition
Conservative transposition is a cut and paste mechanism whereby the trans-
poson is excised from the chromosome (or plasmid) and integrates into target
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DNA. The transposon is lost from the original via this mechanism. The steps
taken during conservative transposition are illustrated in Fig.1.1.
1.9.2.2 Replicative Transposition
Two models of replicative transposition exist, the first such model suggests
that the transposon is replicated during the cellular DNA replication process
when it transposes from a site that has already undergone replication to a site
that is yet to undergo replication (Chen et al., 1992). This model suggests
that transposition is more likely to occur following DNA replication.
Another model for replicative transposition is based on the formation of a
double stranded DNA break that occurs at the site of excision leading to the
repair of the DNA based on a homologous template. This template can either
be DNA from the original chromosome in which case the transposon is lost,
however if the template is the sister chromatid containing the transposon,
then the transposon will be restored (Skipper et al., 2013).
1.9.2.3 Retrotransposons
Retrotransposons transpose either by the process of reterohoming or retero-
transposition (Beauregard et al., 2008). In the process of reterohoming the
excised RNA reverse splices into one strand of the DNA target site, after
which it is reverse transcribed producing the DNA copy (Beauregard et al.,
2008). During the RNA splicing, a ribonucleoprotein complex is formed that
mediates the process. As well as being responsible for the reverse transcrip-
tion of the bacterial interon, the interon encoded protein (IEP) also functions
as a DNA endonuclease cleaving the target DNA site and creating a primer
for the reverse transcription process, and also as an RNA maturase which
stabilizes the catalytically active RNA for splicing (Beauregard et al., 2008).
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Figure 1.1: Orange = inverted terminal repeats, blue=central regions, green cir-
cles=transposase enzymes. Diagram illustrating the steps in conservative transpo-
sition. First, the transposase enzymes bind to the two inverted terminal repeats
that flank the transposon forming the transposition complex, following this the
DNA bends allowing the transposes to interact, this activates the complex caus-
ing the transposase enzymes to cut the DNA and the transposon is excised. The
transposon remains circular until the transposase binds to the target DNA and
cuts the target site allowing for the integration of the transposon(Skipper et al.,
2013).
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Following reverse splicing into DNA, the second strand is cleaved downstream
of the intron insertion site and full length cDNA synthesis can occur (Beau-
regard et al., 2008). Some group II interons do not contain the endonuclease
domain which leaves them unable to cleave the target DNA site, following
the first steps, these group II interons recruit a variety of host functions in
order to complete the process (Beauregard et al., 2008).
The process of retrotransposition begins with the transcription of transposon
DNA to RNA. Retrotransposition requires at least two enzymes, an integrase
which cuts the DNA integration site forming a staggered break, and reverse
transcriptase that reverse transcribes RNA transcript to DNA. Retrotrans-
posons have evolved primarily in eukaryotic organisms though they are found
across all three domains of life (Beauregard et al., 2008). Retrotransposons
are divided into four subgroups (Eickbush and Jamburuthugoda, 2008), the
subgroup that are present within bacteria are group II iterons. Retrotrans-
position was first studies in Lactococcus lactis (Cousineau et al., 2000). The
sequence requirement for retrotransposition is more relaxed than it is for
retrohoming. The intron targets ssDNA as opposed to dsDNA and uses
the replication fork to prime the synthesis of cDNA therefore not requiring
endonuclease action (Beauregard et al., 2008).
1.9.2.4 Inverted Terminal Repeats
Inverted terminal repeats are located at both ends of transposons, they refer
to a sequence of nucleotides that is inverted at the other end of the transposon
for, an example is shown in Figure 1.2. ITRs facilitate movement as they
contain transposase binding sites, transposase catalyses the movement of the
transposon by binding to these sites and cleaving the DNA (Derbyshire and
Grindley, 1992; Ichikawa et al., 1987). Any DNA that lies between the two
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ITRs is moved as shown in Figure 1.1.
Figure 1.2: Illustration representing a transposon, the inverted terminal repeats
are shown in the green sections. Inverted terminal repeating sequences that are a
common feature of many transposons.
ATCGCA TGCGAT
TAGCGT ACGCTA
1.9.2.5 Miniature Inverted-repeat Transposable Elements (MITEs)
Miniature inverted repeat transposable elements are small, generally less than
300bp and contain inverted terminal sequences (Bardaji et al., 2011). The
small size of MITEs results in their activity having a high impact on the
prokaryotic genome allowing them to contribute to phenotypic variation via
the generation of new alleles or by generating new regulatory signals for pre-
existing genes (Bardaji et al., 2011; Delihas, 2008). MITEs lack genes en-
coding transposase and are therefore dependent on autonomous DNA trans-
posons for their mobilisation (Munoz-Lopez and Garcia-Perez, 2010).
1.9.2.6 One Ended Transposition
One ended transposition refers to replicon fusion that takes place when only
one end of the transposable element is present. This mechanism was pri-
marily studied using artificial constructs of the transposons Tn3, Tn21 and
Tn1721 that retained the transposase gene yet had only one inverted terminal
repeat(Liebert et al., 1999). The cointegrates that are formed in one ended
transposition are composed of variable lengths of the donor replicon and the
complete target replicon. One ended transposition also exists in nature as
well as in artificial constructs. The insertion sequence IS102 from Shigella
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dysenteriae mediates co-integration via one ended transposition (Machida
et al., 1982).
1.9.2.6.1 Composite Transposons Class I composite transposons are
characterised by being flanked by two insertion sequences and transpose via
a conservative cut and paste mechanism (Kleckner, 1981). These insertion
sequences carry a transposase gene that encodes a protein that catalyses
the transposition reaction. The DNA that is located in between the two
insertion sequences is typically not involved in transposition itself although
these accessory genes may be important in the maintenance of a transposable
element within a bacterial population. An example of this is a transposon
that contains a gene that confers resistance to antibiotics or heavy metals
thereby providing a selective advantage to host bacteria that contain the
transposon (Ochman et al., 2000). As insertion sequences are transposable
elements, it is possible for the insertion sequences at the flanking regions
of composite transposons to move independently of the whole transposon
(Hallet and Sherratt, 1997). This possibility has been eliminated in the case
of the composite transposons Tn5 and Tn10 however, as these only one
of their insertion sequences contains an active transposase (Ochman et al.,
2000).
1.10 Conjugative Transposons
Conjugative transposons are transposable DNA elements that are able to
excise from the host chromosomal or plasmid DNA that they are integrated
within and form a circular transfer intermediate (Salyers et al., 1995; Scott,
2002). A single stranded form of this circularised DNA is able to transfer to a
recipient cell via conjugation where it is integrated into recipient host DNA
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after first becoming double stranded (Ochman et al., 2000). Conjugative
transposons are a diverse group of elements that were first identified in Gram
positive cocci, conjugative transposons have since been identified in Gram
negative bacteria and the proteobacteria (Ochman et al., 2000). There is a
diversity in the nomenclature regarding conjugative transposon classification,
with some conjugative transposons being assigned a Tn number as in the case
with Tn916 with others being given a CTn label such as CTnERL identified
in Bacteroides. Some conjugative transposons are given an ICE number with
ICE referring to “integrative conjugative element”.
There is a diverse range in size of conjugative transposons, for example Tn919
is 15.4kb compared to the much larger 70kb Tn5276 (Fitzgerald and Clewell,
1985; Salyers and Shoemaker, 1994). Overall the conjugative transposons are
a diverse group of mobile elements however, there are some features that are
common to the group such as the necessity to form circular intermediates
for conjugative transfer. However some non conjugative transposons such as
IS911 also form circular transposition intermediates, therefore the formation
of a circular transposition intermediate does not necessarily make a transpo-
son conjugative (Ochman et al., 2000). A circular intermediate is necessary
for transposition because the origin of transfer oriT is located towards the
centre of the transposon rather than at the terminus. Another feature that
is shared throughout conjugative transposons is that they all integrate into
the recipients DNA (both genomic and plasmid) after they transfer. This
integration is characterised by the integrases which are encoded by the trans-
poson, these integrases are distantly related to one another sharing residues
in the presumed catalytic region (Hallet and Sherratt, 1997; Ochman et al.,
2000). Site specificity for integration varies between different conjugative
transposons, for example Tn916 integrates almost randomly into host DNA
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however it has a preference for A-T rich regions (Trieu-Cuot et al., 1993).
Whereas the conjugative element CTnDOT from Bacteroides integrates se-
lectively into approximately seven sites (Cheng et al., 2001).
1.11 Non-Conjugative Transposons
Transposon nomenclature does not indicate whether a transposon is conjuga-
tive or nonconjugative, for example Tn1545 is conjugative whereas Tn1546
is nonconjugative (Salyers et al., 1995).
1.12 Tn916 Family of Elements
In the late 1970s, chromosomal as opposed to plasmid mediated transfer-
able resistance was first discovered (Franke and Clewell, 1981). Experiments
that mated the DS16 strain of Enterococcus faecalis with the plasmid free
strain JH2-2, some of the tetracycline resistant transconjugants contained
the conjugative transposon Tn916 linked to pAD1, a plasmid that had also
transferred from DS16. Some derivatives of DS16 that where pAD1 was ab-
sent were also able to transfer tetracycline resistance to previously sensitive
strains. Further experimentation revealed that this resistance transfer was
mediated by a conjugative transposon that was designated Tn916 (Franke
and Clewell, 1981). This was the first incidence of a conjugative transposon
being found to confer antibiotic resistance (Franke and Clewell, 1981).
The genetic structure of many mobile genetic elements (MGEs) is organised
in a modular manner (Tribble et al., 1999; Caparon and Scott, 1989). These
modules are involved in the excision of the element from the host DNA,
conjugation and integration into the target DNA as well as regulatory and
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accessory functions that are not related to mobility or conjugation (Burrus
et al., 2002). Since the initial discovery of Tn916 there have been numer-
ous MGEs discovered that have genetic similarities to Tn916 (Roberts et al.,
2001). Within this family of elements the genes that encode conjugative and
regulatory proteins are generally conserved whereas variation exists in the
accessory genes as well as the genes that encode the excisionases and inte-
grases or recombinases. Some of the elements within the family have also
been found to contain insertions of other, smaller elements that themselves
confer resistance to other antibiotics such as macrolides (Salyers et al., 1995)
as well as the heavy metal mercury (Scott, 2002). Some of the Tn916 family
contain group II introns and insertion sequences (Teuber et al., 1999). Trans-
posons belonging to the Tn916 family of elements have been found within a
diverse range of species (Hummel et al., 2007; Devirgiliis et al., 2009; Riz-
zotti et al., 2009) meaning that this family of MGEs has an extremely diverse
range of host bacteria (Herzog-Velikonja et al., 1994; Sato et al., 1992; Cao
et al., 1994).
1.12.0.1 Tn916
The transposon Tn916 was initially discovered when tetracycline resistance
was observed to be transferred between Enterococcus faecalis strains DS16
and Enterococcus faecalis JH2-2 without any plasmids being detected (Franke
and Clewell, 1981). The element that was responsible for this resistance
transfer was shown to be the conjugative transposon Tn916. Since this time,
many transposable elements that belong to the Tn916 family of element
have been discovered in a wide range of bacterial species (Agersø et al.,
2006). Tn916 is composed of four regions, each adapted to a specific func-
tion. These functions are regulation, conjugation, recombination and acces-
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sory genes that are not involved in the process of conjugative transposition
(Senghas et al., 1988). Such accessory genes may offer selective advantages
to hosts that contain the transposon such as antibiotic resistance genes. In
the case of Tn916 the accessory gene is tetM, a gene that confers resistance
to the antibiotic tetracycline.
For an element to be considered a member of the Tn916 -like family, specific
criteria must be met, these criteria are based upon the organisational struc-
ture of the element, the core region must be similar at a DNA level to the
original Tn916 element.
The detection of int and xis along with tetM and in some cases ermB 4.10
hint at the possibility of a Tn916 -like element being present in these iso-
lates, however there is not enough information to confirm this with certainty,
further PCRs to test for other regions of Tn916 would be required. The
Tn916 family has already been detected in many of the species that have
been identified in this study. Of the species that tested positive for int and
xis suggesting that an element related to Tn916 may be present (S. aureus,
S. agalactiae, S. dysgalactiae, S. hominis and S. pyogenes. Transposons be-
longing to the Tn916 family have been previously detected in and known to
exist within populations of S. aureus (De Vries et al., 2009), S. agalactiae
(Rice, 1998), S. dysgalactiae (Haenni et al., 2010), and S. pyogenes (Feng
et al., 2010). There has been no report of the tetM gene or any Tn916 -
like transposons being detected in S. hominis or S. simulans, tetM was also
not detected in these isolates however the int and xis genes were detected
via PCR in S. hominis suggesting that this species may have acquired an
element related to Tn916 however these genes were not detected in S. sim-
ulans. The erythromycin resistance determinant ermC was also detected in
one isolate of S. hominis and S. simulans, the genetic support of ermC is
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Figure 1.3: Schematic diagram of Tn916 with the modules associated with dif-
ferent functions highlighted. Green: conjugative transfer, blue: transcriptional
regulation, yellow: recombination.
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usually plasmid mediated and this gene has not been detected on a transpo-
son, however this does not mean that it is definitely located on a plasmid,
as ermB was originally discovered on a plasmid pCA1 (Clewell and Franke,
1974) and has since been detected upon transposons such as Tn917 (Perkins
and Youngman, 1984).
The tetracycline resistance determinant tetM has been detected in C. stria-
tum (Martinez-Martinez et al., 1996). However transposable elements that
belong to the Tn916 family have not been reported in this species. The tetW
gene was first reported in C. striatum in China (Li et al., 2015). To date this
is the only reported incidence of tetW in C. striatum.
1.12.1 Modular Function
Elements in the Tn916 family contain open reading frames that are organised
into functional modules (Senghas et al., 1988). These modules are involved
in processes such as conjugation, transcriptional regulation, recombination as
well as accessory functions such as antimicrobial resistance genes (Flannagan
et al., 1994). The different modules of Tn916 are shown in Figure 1.3.
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1.12.2 Structural Organisation of Tn916
The original Tn916 was first isolated from Enterococcus faecalis (Franke
and Clewell, 1981). This element is the original model of a large family of
conjugative transposons that reside within a diverse range of host bacteria.
There are 24 open reading frames that comprise the structure of Tn916, these
ORFS encode putative proteins that have a molecular mass that ranges be-
tween 2.9 and 93.7 kDa. The majority of elements that belong to the Tn916
family carry the accessory gene tetM that confers resistance to tetracycline.
An exception is Tn5386 that was originally isolated from Enterococcus fae-
cium, this element contains ORFs that with homology to genes that confer
resistance to the lantibiotics class of antibiotics (Rice et al., 2007).
1.12.3 Tn916 and Other Elements
Tn916 elements may contain insertion sequences, if two identical IS were
inserted into a Tn916 like element, then the sequence between the two IS
could become incorporated into a class II transposon and move to another
location on the genome (Perreten et al., 1997). Tn916 may also be associated
with nonconjugative elements, for sample Tn917, a transposon that carries
the erythromycin resistance determinant ermB (McDougal et al., 1998). The
resulting transposon, Tn3872 confers resistance to both tetracycline and
erythromycin.
1.12.4 Tn916 and Conjugation
The conjugation of Tn916 contributes to the spread of antibiotic resistance
genes. For conjugation to be initiated the relaxase encoded by ORF20 must
nick oriT, which is 466bp in length and lies between orf21 and orf20, it
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is made up of 6 sets of inverted repeats (Jaworski and Clewell, 1995) oriT
also interacts with the Tn916 tyrosine recombinase (Rocco and Churchward,
2006).
1.12.5 Regulation of Tn916
The region of Tn916 that is associated with regulation is composed of orf7,
orf8, orf9 and orf12 and is conserved throughout the majority of the elements
in the Tn916 family (Su et al., 1992; Celli and Trieu-Cuot, 1998).
orf12 is 86bp in length, it encodes several inverted repeat sequences that
can form hairpin structures in mRNA followed by uridine residues, which
are speculated to be a rho factor independent transcriptional terminator (Su
et al., 1992). orf12 also contains rare codons that function to couple the
expression of orf12 and the genes present downstream of it such as tetM.
1.12.5.1 Tn916 in the Absence of Tetracycline
Tn916 in typical growth conditions where tetracycline is absent, the ribosome
stalls around the leader sequences of orf12 due to a lack of tRNA modules
for the codons that are present at the beginning of orf12. This stalling causes
the ribosome to lag behind the RNA polymerase which causes a termination
of transcription in the majority of cases therefore limiting the expression of
TetM. A basal level of TetM is maintained within the cell by instances where
the RNA polymerase breaks free of the termination site and reads through
into tetM and transcribes it. This basal level of TetM in the absence of
tetracycline provides protection to some of the cellular ribosomes should the
bacteria become exposed to tetracycline (Su et al., 1992).
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1.12.5.2 Tn916 in the Presence of Tetracycline
Tn916 regulation involves a mechanism called transcriptional attenuation,
this involves an interaction between tetracycline and the ribosomes that re-
moves the transcriptional terminator (Su et al., 1992). Tetracycline renders
most of the ribosomes inactive via reversible binding. Due to the low level of
ribosomal protection provided by basal TetM levels, protein synthesis does
not cease completely however it is slowed down which results in an accu-
mulation of charged tRNA. The increased availability of tRNA leads to an
increase in the translation of orf12 by the ribosomes that have been protected
by TetM. Transcription occurs from the promoter that is present upstream
of orf12 and travels downstream through tetM and surrounding ORFs.
Once the majority of ribosomes have been protected by TetM, the expression
of tetM returns to lower levels as the availability of charged tRNA molecules
is reduced due to many of them having been recruited for the protected
ribosomes.
1.12.5.3 Tn916 Promoters
Tn916 contains four promoters, these are PtetM, Porf7, Porf9 and Pxis (Celli
and Trieu-Cuot, 1998). When tetracycline is absent, the expression of orf9
causes the downregulation of promoter Porf7 resulting in a reduction of down-
stream genes including orf7 and orf8. The expression of orf9 is reduced in the
presence of tetracycline which results in the upregulation of Porf7 increasing
expression of orf7, orf8 and other downstream genes (Celli and Trieu-Cuot,
1998).
The linking of Tn916 regulation to the presence of tetracycline allows the
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bacteria to react to the presence or absence of tetracycline via the down-
regulation or upregulation of gene expression within Tn916 increasing the
expression of tetM when it is necessary (Celli and Trieu-Cuot, 1998).
1.13 Aims and Objectives
The overall aim of this project was the investigation into the molecular basis
of bacterial antimicrobial resistance. A method was developed allowing for
the rapid screening of Tn916 based on PCR producing two large amplicons
which were subsequently digested providing a restriction profile allowing the
identification of Tn916.
The collection of clinical isolates obtained from patients at the Queen Eliza-
beth hospital in Norfolk, focusing primarily on tetracycline and erythromycin
resistance in Streptococcus and Staphylococcus species.
The investigation of antibiotic resistance in saliva that was collected from
healthy volunteers, analysing the antimicrobial resistance genes that are
present within the metagenomes of these individuals as well as using cul-
ture to investigate the different species of resistant bacteria that are present
with a focus on tetracycline and erythromycin antibiotics.
The transposon-aided capture (TRACA) technique was also employed in or-
der to characterise the plasmid population that is present within these saliva
samples.
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Chapter 2
Materials & Methods
All antibiotics were purchased from Sigma Alderich. All agar and media was
purchased from Thermo Scientific unless otherwise stated.
2.0.1 Primer Design
Primers for PCR and DNA sequencing were designed by manually selecting
a region of DNA that was 21bp in length, the DNA was analysed using IDT
oligo analyser to check that the primers were of a sufficient standard. The
criteria included were that the primer must have a %GC content of between
40% and 60%, the melting temperature must be between 50oC and 59oC, and
the self and hetero dimer delta G score (referring to the amount of energy
required to break the dimer bonds) was below -10kcal/mole. These properties
were analysed using the program OligoAnalyzer (IDT).
2.0.2 Polymerase Chain Reaction
Polymerase chain reaction (PCR) was performed by combining the reagents
as shown in Table 2.1, the reactions were run on a thermocycler under con-
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ditions that were specific for each reaction based upon the product size and
primer melting temperature. Biomix Red is a ready made mastermix pro-
duced by Bioline, the details of the concentrations of Biomix Red are propri-
etary, however it contains reaction buffer, dNTPs and MgCl2.
Table 2.1: Each polymerase chain reaction contains the reagents and volumes
detailed in this table.
Reagent Volume Starting conc. Final conc.
Biomix Red 12.5 µl 2x 1x
ddH2O 9.5 µl − −
Forward primer 1 µl 10µM 0.4µM
Reverse primer 1 µl 10µM 0.4µM
Template DNA 1 µl variable variable
2.0.3 Gel Eletrophoresis
Agarose gels were prepared at a concentration of 0.75%. The agarose and tris
acetate EDTA(TAE) buffer were microwaved until the agarose had melted,
this solution was allowed to cool briefly for approximately 5 minutes before
having GelRed (Biotium) added to it to a concentration of 1.25%. The
gel was then mixed and poured into a casting tray and allowed to set over
the course of 20 minutes. The set gel was transferred to an electrophoresis
tank where it was submerged in TAE buffer where 2.5µl of the relevant
DNA ladder was loaded into the first well followed by 2.5µl of each sample.
Electrophoresis was carried out at 100 volts over the course of 1 hour. The
outcome of the gel was visualised under ultra-violet light.
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2.0.4 Processing of Saliva Samples
Approximately 5ml saliva samples were obtained from healthy volunteers.
The samples were diluted in BHI broth to 10-3 and 10-4 before 100µl was
spread on to brain heart infusion (BHI) agar that contain 20 % defibrinated
horse blood as well as either 4 µg/ml tetracycline or erythromycin.
The serial dilution steps taken during sample dilution are as follows:
100µl saliva −→ 900µl BHI = 1ml 10-1
100µl 10-1 −→ 900µl BHI = 1ml 10-2
100µl 10-2 −→ 900µl BHI = 1ml 10-3
100µl 10-3 −→ 900µl BHI = 1ml 10-4
2.0.5 Freezing Down Isolates for Storage
Isolates were grown in 5ml BHI broth overnight at 37◦C for 24 hours aerobi-
cally with shaking. Following incubation 1ml of overnight broth was mixed
with 1ml BHI broth containing 20% glycerol to produce a final glycerol per-
centage of 10%. The isolates were immediately stored at -80oC.
2.0.6 Preparation of Media
For molecular cloning using E. coli lysogeny broth (LB) medium was used.
For growing strains isolated from wounds brain heart infusion (BHI) medium
combined with 20% difibrinated horse blood (Thermo) was used.
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2.0.7 DNA Extraction using FastDNA Spin Kit for
Soil (MP Bio)
Saliva samples were centrifuged at 4000g for 15 minutes to pellet bacteria.
The pellet was re-suspended in 978µl sodium phosphate buffer and 122µl MT
buffer before being lysed by the FastPrep Instrument (MP Bio) for 40 sec-
onds at a speed setting of 6.0. The lysed cells were centrifuged at 14000g for
10 minutes and the supernatant transferred to a clean 2ml microcentrifuge
tube and combined with 250µl protein precipitation solution then inverted
10 times. The mixture was centrifuged at 14000g to separate the precipi-
tated protein, the supernatant was combined with 1ml binding matrix and
mixed via rotation for 2 minutes before being left to settle for 3 minutes.
500µ supernatant was discarded and the remaining supernatant was passed
through the SPIN Filter (MP Bio) via centrifugation at 14000g for 1 minute.
The DNA was eluted in 100µl ddH2O and stored at -20
oC.
2.0.8 DNA Extraction Using Glass Beads
1µl of bacterial cells were suspended in a combination of 40µl H2O, 160µl
0.05mM NaOH and glass beads (sizes 425 - 600µm and ≤106µl) and vortexed
thoroughly, the mixture then was incubated at 80oC for 45 minutes, then
allowed to cool to room temperature for 10 minutes. Once the mixture had
cooled, 36µl of Tris-HCl (1M) is was added. It was subsequently centrifuged
at 4000rpm for 10 minutes and the supernatant was retained and stored at
-20oC.
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2.0.9 Plasmid Extraction
E. coli bacterial hosts were incubated overnight at 37oC aerobically while
shaking in 5ml LB broth containing relevant antibiotic acting as a selective
marker, in the case of pUC19 or T-Eazy this was 100µg/ml ampicillin, for
pCC1BAC this was 12.5µg/ml chloramphenicol. Plasmids were extracted
from the overnight culture as described in the protocol supplied with the
QIAprep Spin Miniprep Kit (Qiagen). Quality and quantity of plasmid yields
were assessed by Qubit analysis and gel electrophoresis on a 1.5% gel for 1
hour.
2.0.10 PCR Product Clean up
PCR product was cleaned up using the QIAquick PCR Purification Kit in
accordance with the manufacturers protocol (Qiagen).
2.0.11 DNA Extraction from Agarose Gels
Bands of DNA were visualised on UV transillumiator and cut from the re-
maining gel using a scalpel. The DNA was extracted from the gel cut out
using the ISOLATE II PCR and Gel Kit (Bioline) in accordance with the
protocol supplied by the manufacturer.
2.0.12 Quantification of Extracted DNA
The working solution was prepared by preparing a 1:200 dilution of Qubit
reagent into Qubit buffer, 1µl of DNA was added to 199µl working solution,
mixed via vortex and incubated for 2 minutes before being read using the
Qubit fluorometer. This method was used to quantify all extracted DNA.
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2.0.13 Restriction Digestion
Restriction digestion has been carried out using the enzymes HincII (Promega),
HindIII (Promega) and Sau3AI (NEB) in according to the protocols supplied
with these enzymes.
2.1 Minimum Inhibitory Concentration (MIC)
Testing
2.1.1 Preparation of Antibiotics
The antibiotics ampicillin, kanamycin and chloramphenicol were dissolved in
ddH2O. Tetracycline was dissolved in 50% ethanol/50% H2O, the antibiotics
vancomycin and erythromycin were dissolved in 100% ethanol.
2.1.2 Preparation of Inoculum
The inoculum is prepared by growing the isolates overnight on ISO sensitest
agar in accordance with Table 2.2. Approximately 4-5 of these colonies are
resuspended in ISO sensitest broth. The absorbance of the resuspended bac-
teria is measured using a UV spectrophotometer at a wavelength of 650nm.
The absorbance reading determines the amount of this broth that is added
to 5ml sterile broth, the volume added based for each absorbance reading is
shown on Table 2.2.
2.2 Speciation of Bacteria
The species of bacteria was determined using PCR to amplify the 16S gene,
and compare it with the NCBI database as described in Section 4.2.4.
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Table 2.2: Dilution of bacterial suspensions adapted from BSAC susceptibility
guidelines.
Absorbance Reading at 650nm Volume(µl) to transfer to 5ml H2O
Staphylococci >0.3 – 0.6 20
Streptococci >0.05 – 0.1 250
Enterococci >0.05 – 0.1 125
2.3 Molecular Cloning
2.3.1 Ligation
Ligation reaction mixture was prepared as described in Table 2.3 and incu-
bated at 22oC for 10 minutes..
Table 2.3: Reagents and volumes used in the ligation reaction, the ligation mixture
was heated at 25oC for 15 minutes. The reaction buffer contains 400mM Tris-HCl,
100mM MgCl2, 100mM DTT, 5mM ATP and had a pH of 7.8 at 25
oC.
Reagent Volume Concentration
H2O Make up to 20µl total −
2x Buffer 10µl 10x
Vector Variable 1mg/ml
DNA Variable 1:1-5:1 ratio with vector
T4 Ligase 1µl 1U/µl
Total 20µl
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2.3.2 Desalting of Ligation Reaction
Agarose cones were produced by heating 0.9g glucose, 0.5g agarose and 50ml
H2O in a microwave, cooled to 50
oC and 800µl was pipetted into a 1.5ml
microcentrifuge tube. A 0.5ml microcentrifuge tube was placed in this molten
solution in order to act as a mould. The solution was then left to solidify
and the 0.5ml tube removed. The ligation reaction was transferred to the
agarose cone for 1 hour to allow any salt present in the solution to diffuse
into the glucose-agarose cone.
2.3.3 Transformation using pUC19
The procedure for transforming DNA into the vector pUC19 is adapted from
the protocol for α-select Gold Competent Cells (Bioline). Once the compe-
tent cells had been thawed on ice, 50µl cells and 5µl of ligated DNA were
mixed together and agitated gently. The resulting mixture was then left in-
cubating on ice for 30 minutes before being transferred to a water bath at a
temperature of 42oC for 30 seconds to heat shock the cells. Following this the
tubes were returned to ice for 2 minutes. 950µl of SOC media (Sigma) was
added to the reaction which was then incubated while shaking at 37oC for 1
hour, 200µl of transformed was spread onto LB agar plates that contained
100µg/ml ampicillin and 4µg/ml tetracycline that were incubated at 37oC
overnight.
2.3.4 Electroporation
The electroporation cuvettes and 1.5ml micro-centrifuge tubes were pre-
chilled on ice. 2µl of the desalted ligation reaction that was prepared in
Section 2.3.1 was combined with 50µl of Transformax EPI300 Electrocompe-
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tent E. coli cells (Epicentre) and transferred to the electroporation cuvette.
Electroporation was carried out at 1800V, 25µF and 200Ω. 950µl SOC media
was added to the electroporated cells and they were transferred to a 15ml
tube and incubated for 1 hour at 37oC with shaking before 100µl was plated
onto LB plates that contained 12.5µg/ml chloramphenicol and incubated
overnight at 37oC.
54
2.3.5 Strains used throughout study
Table 2.4: List of bacterial strains that were used throughout the study. A more
detailed list containing the specific attributes of each isolate/clone is presented in
Appendix .1
Species Isolate IDs
Bacillus subtilus BS34A CU2189
Staphylococcus aureus QE01 QE02 QE03 QE04 QE05 QE06 QE07 QE08 QE09 QE10 QE11
QE12 QE13 QE14 QE15 QE16 QE17 QE18 QE19 QE20 QE21 QE22
QE23 QE24 QE25 QE26 QE27 QE28 QE29 QE30 QE31 QE32 QE33
QE34 QE35 QE36 QE47 QE50 QE55 QE56 QE69 QE70 QE82 QE83
QE84 QE85 QE86 QE94
Streptococcus agalactiae QE40 QE45 QE48 QE49 QE89 QE96 QE98 QE102
Streptococcus dyscalactiae QE41 QE95 QE99 QE107 QE111
Streptococcus group A QE37 QE38 QE39 QE43 QE44 QE51 QE52 QE53 QE54 QE57 QE58
QE60 QE61 QE62 QE63 QE64 QE65 QE66 QE67 QE68 QE71 QE72
QE73 QE74 QE75 QE76 QE77 QE78 QE79 QE80 QE81 QE87 QE88
Streptococcus group B QE103
Streptococcus group C QE46
Streptococcus group G QE90 QE101 QE105 QE109 QE112
Corynebacterium striatum QE92 QE93 QE106
Enterococcus faecalis QE113 QE114 QE115 QE116 QE117 QE118 QE119 QE120 QE121
QE122 QE123 QE124 QE125 QE126 QE127 QE128 QE129 QE130
QE131 QE132 QE133 QE134 QE135 QE136
Escherichia coli K-12 TRACA1 TRACA2 TRACA3 TRACA4 TRACA5 TRACA6 TRACA7
TRACA8 TRACA9 TRACA10 TRACA11 TRACA12 TRACA13
TRACA14 TRACA15 TRACA16 TRACA17 TRACA18 TRACA19
TRACA20 TRACA21 TRACA22 TRACA23 TRACA24 TRACA25
TRACA26 TRACA27 TRACA28 TRACA29 TRACA30 TRACA31
TRACA32 TRACA33 TRACA34 TRACA35 TRACA36 TRACA37
TRACA38 TRACA39 TRACA40 TRACA41 TRACA42 TRACA43
TRACA44 TRACA45 TRACA46 TRACA47 TRACA48 TRACA49
TRACA50 TRACA51 TRACA52 TRACA53 TRACA54 TRACA55
TRACA56 TRACA57 TRACA58 TRACA59 TRACA60 TRACA61
TRACA62 TRACA63 TRACA64 TRACA65 TRACA66 TRACA67
TRACA68
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Chapter 3
Investigation into Resistance
Genes and Mobile Elements in
the Oral Cavity
3.1 Bacteria in the Oral Cavity
3.1.1 Introduction to the Oral Microbiome
The human microbiome has been co-evolving alongside humans throughout
history developing into a symbiotic relationship conferring benefits to both
humans and microbiota (Clemente et al., 2012; Hooper and Gordon, 2001).
The human oral microbiome is composed of bacteria, archaea, viruses fungi
and protozoa (Wade, 2013). Some bacteria that reside within the oral cavity
are responsible for two common diseases that are found within humans, these
being dental caries and periodontal disease. The human oral microbiome is
home to a large number of diverse bacterial species, approximately 1000
different species of bacteria have been found within the oral cavity (Wade,
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2013). The community of bacteria that reside within the oral cavity has been
shown to be the second most complex bacterial community following those
in the colon (Wade, 2013).
3.1.2 The Role of Oral Bacteria in Health and Disease
The acquisition of the oral microbiome begins with vertical transmission from
the mother to the child during childbirth, the composition of the oral mi-
crobiome is influenced by the method of delivery (i.e. Caesarian or vaginal),
it has been observed that in 3 month old infants that were delivered via
a vaginal childbirth that their oral microbiome shows a higher taxonomic
diversity than those delivered by Caesarian (Dominiguez-Bello et al., 2010;
Zaura et al., 2014). It has also been observed that infants who were de-
livered via Caesarian acquired the pathogenic bacteria Streptococcus mutans
approximately a year earlier than infants born via vaginal childbirth (Li et al.,
2005) which suggests that it’s possible that the method of childbirth could
have a lasting impact upon the oral microbiome (Costello et al., 2013; Zaura
et al., 2014). In addition to the method of childbirth, the initial develop-
ment of the oral microbiome is also influenced by whether the infant is fed
using breast milk or with formula milk (Romani Vestman et al., 2013). In
breastfed infants, Lactobacillus was observed to have colonised the oral cav-
ity significantly more frequently than infants who had been fed with formula
milk (Vestman et al., 2013). In another study, Lactobacillus isolates were
cultured from breast fed infants and tested for their ability to inhibit the
growth of Streptococcus mutans and Streptococcus sanguinis, it was observed
that the Lactobacillus isolates did inhibit the growth of the Streptococcus
isolates, which may suggest a potential mechanism explaining the difference
within the oral microbiota between infants fed with breast milk and infants
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fed with formula milk in that the Lactobacillus bacteria indigenous to breast
milk may suppress the growth of other bacterial species (Holgerson et al.,
2013). In addition to the vertical transfer of bacteria from the parent to the
infant, the developing oral microbiome is influenced by horizontal transfer
from other individuals within the same environment such as siblings (Baca
et al., 2012; Stahringer et al., 2012; Zaura et al., 2014).
3.2 Diseases of the Oral Cavity
3.2.1 Dental Caries
Dental caries (tooth decay) is a common infectious disease found in humans,
there has been a reduction in the incidence of dental caries within popu-
lations where the fluoridation of public water has taken place as such the
prevalence of dental caries varies in between different populations, in certain
populations there is an epidemic of this disease (Scannapieco, 2013). Dental
caries is considered to be a poly-microbial disease involving multiple species
of bacteria, a group of bacteria that play a pivotal role in the development
of dental caries is the carcinogenic streptococci. This group includes the
streptococcal species S. mutans, S. aureus, S. cricetus, S. macacae, and S.
downeii. These bacteria metabolise dietary sugar into lactic acid as well
as producing polysaccharides that are involved in biofilm production, these
polysaccharides slow the rate in which the lactic acid is able to diffuse away
from the surface of the tooth therefore increasing tooth demineralisation. In
order to acquire this disease state, both the carcinogenic bacteria and fer-
mentable carbohydrates are required (Scannapieco, 2013). As well as the
carcinogenic streptococci, the presence of acidogenic lactobacilli has been
observed within carious lesions, however these lactobacilli are considered to
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be primarily involved with the progression of the disease state as opposed
to its initiation, it is also possible that the development of dental carries
is influenced by the base producing microorganisms within the oral biofilm
which may have a buffering effect upon the lactic acid that’s being produced
(Scannapieco, 2013).
Dental caries is a common disease found in children and can occur soon
after the teeth have erupted. In less severe cases this disease leads to an
impaired quality of life and is a source of pain however this disease can lead
to hospitalisation and fatality in the most serious cases (Gross et al., 2012).
Research that has recently been carried out using molecular techniques such
as 16S rDNA profiling in order to catalogue the bacterial species present
within dental caries has suggested that there are a number of other species
of bacteria that are over represented in carious lesions besides S. mutans and
lactobacilli, these include Neisseria, Bifidobacterum, Selenomonas , Propri-
onibacteria as well as other species of streptococci (Peterson et al., 2013).
Another study investigating early childhood caries used anaerobic culture
methods to investigate the microbiota present in serious cases of this disease
and observed that the species that were associated with severe early child-
hood caries included S. mutans as other studies show, however alongside S.
mutans the following species were also shown to have an association with
this disease state: Veillonella parvula, Acinomyces gerensceriae, Scardovia
wiggsiae and Streptococcus cristatus (Tanner et al., 2011). It is speculated
that increase in the numbers of Veillonella in caries is likely to be because
within the carious lesion there is abundant environmental lactate present
and Veillonella is able to metabolise lactate and is therefore able to survive
within this environment (Scannapieco, 2013).
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3.2.2 Periodontal Diseases
Periodontal diseases occur as a result of bacteria that live in poly-microbial
biofilms either at or below the gingival margin, these diseases progress largely
due to an inflammatory response that is initiated by subgingival species
(Borgnakke et al., 2013; Teles et al., 2013). Bacteria are able to colonise the
tooth surface within a few hours of tooth cleaning, this colonisation primarily
occurs in the regions of the gingival margin as well as the inter-dental spaces.
The biofilm that is developing in these regions is responsible for producing
various biologically active products that include endotoxins, protein toxins,
chemotactic peptides and organic acids. Such products diffuse into the gin-
gival epithelium, initiating the host response eventually leading to gingivitis
(Kornman et al., 1997). The clinical description of gingivitis is recognised
by a colour change in the gums from Pink to red, this colour change is ac-
companied by other symptoms such as bleeding and swelling, due to the fact
that in most cases this disease state is not painful, it may remain untreated
in individuals for a significant amount of time. Gingivitis may progress in to
periodontitis, periodontitis is a more serious disease state that refers to the
destruction of the supporting bone of the tooth and the periodontal ligament
alongside the inflammation of the gingiva that is characteristic of gingivitis,
if the condition periodontists remains untreated then it can result in the de-
struction of the supporting tissues of the tooth ultimately leading to tooth
loss (Scannapieco, 2013). There are environmental and endogenous factors
that are associated with an increased incidence of periodontist, these fac-
tors include stress, oral hygiene, obesity, smoking as well as potential genetic
associations (Curtis et al., 2011). The bacteria that reside within the oral
cavity are necessary for both the onset and the progression of periodontal
disease (Teles et al., 2013). Research that is focused upon culture based
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methods have indicated that different bacteria are involved with different
forms of this disease, for example in the case of gingivitis, the flora shifts
from what is predominantly an environment that contains facultative Gram
positive bacteria that contains a high percentage of Streptococci to a flora
that is associated with increased levels of Gram negative bacteria, commonly
of the genera Campylobacter, Capnocytophaga, Fusobacterium (Haffajee and
Socransky, 2005). However the condition periodontitis is associated with a
shift to mostly anaerobic species, such species include Tannerella forsythia,
Porphyromonas gingivalis and Treponema denticola (Scannapieco, 2013). In
addition to the presence of pathogenic bacteria, periodontitis also occurs as
a result of the inflammatory response mediated by the immune system of the
host. In addition to virulence factors, pathogen associated molecular patterns
are displayed by such bacteria, these structural moieties are recognised by the
pathogen recognition receptors in the host, such receptors contribute to the
development of inflammation by activating downstream signalling pathways
in inflammatory cells which then leads to an increase in the production of in-
flammatory cytokines which then in turn leads to the onset of both local and
systemic inflammation (Haffajee and Socransky, 2005). Based on such obser-
vations it is therefore possible to conclude that periodontal pathogenesis is a
result of a complex yet subtle interactions between both the bacterial species
that reside within the oral microbiome and cells that belong to the host.
A community of bacteria which is potentially pathogenic may arise from a
small number of bacteria, these bacteria are named “keystone pathogens”
(Darveau et al., 2012). These bacterial species influence the host immune
response in such a manner that results in an impaired immune surveillance
as well co-opting other species of bacteria that typically reside in the oral
cavity to contribute to pathogenesis. Therefore it is possible that disease
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expression may be a result of a limited yet changing group of bacteria, the
combined actions of which promote the inflammatory response within the
host and the subsequent tissue destruction (Scannapieco, 2013).
3.2.3 Endodontic Infections
An endodontic infection is most likely to occur once bacteria have penetrated
into the root canal system which usually occurs as a result of a dental cari-
ous lesion. However there are other routes of entry that bacteria are able to
exploit, such routes include periodontal disease that leads to access to dental
tubules, tooth abrasion or erosion that exposes the pulp, fracture as a result
of trauma or the microleakage or restorations (Narayanan and Vaishnavi,
2010). The usual result of an endodontic infection is apical periodontitis,
this condition is characterised by the destruction of the bone and the peri-
odontal ligament that surrounds the tooth (Scannapieco, 2013). According
to results of both traditional culture dependent studies as well as modern
molecular culture independent studies, the bacterial species that have been
identified from samples of teeth that have been infected endodontically gen-
erally reflects the bacterial species that comprise the flora of dental plaque.
The genera that have been most commonly observed in such infections in-
clude Lactobacillus, Streptococcus, Prevotella and Eubacterium (Siqueira and
Rocas, 2009). As is the case in the commensal bacteria that reside in the
oral microbiome, many of the bacterial species present are not currently cul-
tivable (Narayanan and Vaishnavi, 2010). In many cases, primary endodontic
infections are mixed infections that involve at least two different species of
bacteria. Secondary endodontic infections occur as a result of either the fail-
ure of the treatment used to treat the initial infection or the recolonisation of
the root canal system (Scannapieco, 2013). Bacterial diversity in secondary
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endodontic infections has been observed to be diminished when compared to
the bacterial diversity in primary endodontic infections however the bacteria
Enterococcus faecalis has often been isolated in these cases (Narayanan and
Vaishnavi, 2010).
3.3 Ethics
The collection of saliva samples was approved by the Anglia Ruskin ethics
committee, project number: FST/FREP/12/349.
3.3.1 Screening Metagenomic DNA for Genes Associ-
ated with Antimicrobial Resistance
Metagenomic DNA was extracted from each of the saliva samples (processed
as described in section 2.0.4) using the FastPREP homogeniser (MP Bio)
as described in section 2.0.7. DNA yields are presented on Table 3.1. Poly-
merase chain reaction (PCR) was employed to screen each metagenomic DNA
sample for the presence of different genes that confer resistance to antibiotics
as well as genes that are associated with mobile elements int and tndX ). This
data is presented on Table 3.2, the profile of each sample appears to be sim-
ilar with 25 of 27 samples containing the tetracycline resistance gene tetM,
all samples tested positive for the presence of the tetracycline resistance gene
tet32 and the int gene that is associated with Tn916 -like transposable ele-
ments. In addition to this, the erythromycin resistance gene ermB was iden-
tified in all samples. However the other resistance genes that were screened
for (tetracycline resistance genes tetQ, tetX, tetX-1 ; erythromycin resistance
genes ermA and ermC, the vancomycin resistance gene vanA, oxacillinase
producing genes OXA23, OXA48, OXA58 and OXA40 were all failed to am-
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Table 3.1: Metagenomic DNA extracted from saliva samples using the FastPrep
homogeniser (MP Bio).
Sample Quantity ng/µl Sample Quantity ng/µl
S1 248 S16 194
S2 230 S17A 35
S3 202 S17B 29
S4 91 S18 20
S5 47 S19 111
S6 111 S20 4.9
S7 36 S21 68
S8 68 S22 111
S9 70 S24 4.9
S10 133 S25 68
S11 192 S26 47.2
S12 172 S27 82
S13 65 S28 150
S14 109 S29 176
S15 216
plify as was the recombinase gene tndX. However it is not possible to conclude
that these genes were absent because no positive controls were included in
these reactions, results presented on Table 3.2.
3.3.2 Analysis of Bacterial Isolates Cultured from Saliva
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Table 3.3: PCR reactions carried out specific for areas of Tn3872 corresponding
with the regions shown in Fig 3.1.
ID Morphology A B C D E F G H I J
S2-1 1 X X X X x X X X X X
S2-2 1 X X X X x X X X X X
S2-3 1 X X X X x X X X X X
S2-4 1 x X X X x x X X X X
S2-5 1 X X X X x X X X X X
S2-7 1 x X x X x x X X X X
S2-8 2 X X X X x X X X X X
S2-9 2 X X X X x X X X X X
S2-10 2 X X X X x X X X X X
S2-11 1 X X X X x X X X X X
S2-12 1 X X X X x X X X X X
S2-13 1 X X X X x X X X X X
S2-14 1 X X X X x X X X X X
S2-15 1 X X X X x X X X X X
S2-16 1 X X X X x X X X X X
S2-17 1 X X X X x X X X X X
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Figure 3.1: Diagram of Tn3872 adapted to show the different regions amplified by
the sets of PCR primers that corresponds with the reactions shown in Table 3.3.
Adapted from (Poyart et al., 2000)
Initial antibiotic resistance selection took place on BHI agar plates that con-
tained 20% defibrinated horse blood and 2µg/ml erythromycin to select for
erythromycin resistant isolates in accordance with BSAC guidelines. Any
colonies that appeared on these plates following incubation at 37oC for 24-48
hours were sub cultured on to further plates that contained the same an-
tibiotic in order to confirm whether or not the resistance was genuine. The
isolates that produced full growth following subculturing were divided based
upon their morphological characteristics and transferred to BHI broth con-
taining 10% glycerol in order to allow storage at -80oC. The isolates were
further tested for resistance to tetracycline at a concentration of 4µg/ml as
well as an increased concentration of erythromycin at 10µg/ml. 16 isolates
that were resistant to both 4µg/ml tetracycline and 10µg/ml erythromycin
were taken forward for further analysis. Further analysis involved investi-
gating what antibiotic resistance genes were present as well as mapping the
mobile element that the genes were located on. This was achieved by screen-
ing for the presence of known resistance genes using PCR. The PCR showed
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that in the case of all 16 isolates, the resistance genes that were present
were tetM which confers resistance to tetracycline and ermB that confers
resistance to erythromycin.
PCR mapping was carried out in order analyse the structure of the element.
The regions that were amplified are illustrated in Fig. 3.1. The PCR results
are shown on Table 3.3. Sections ‘A’, ‘E’, and ‘F’ failed to amplify from
isolate S2-4 and sections ‘A’, ‘C’, ‘E’ and ‘F’ failed to amplify from isolate
S2-7, amplicons were produced for the remaining sections. All sections with
the exception of ‘E’ were amplified in the remaining 14 isolates, suggesting
that the element could be related to Tn916. PCR ‘F’ bridges Tn916 and
Tn917, the amplification suggests that there may have been an insertion at
this point. However because the whole transposon was not amplified and the
amplification results were not verified via DNA sequencing it is not possible
to conclude what these elements are.
These isolates were divided into 2 groups based upon morphology. The
species identity was determined first by the sequencing of the 16S gene which
revealed that in the case of both morphologies the species was Streptococcus
salivarius. This identification was later confirmed by sodA sequencing.
3.3.3 Investigation into isolates from S28
In order to characterise the different species present within the isolates ob-
tained from S28, this sample was selected at random, and selected for us-
ing tetracycline, they have been divided into different groups based upon
morphological characteristics, and screened against tetracycline in order to
confirm resistance, in addition these isolates have also been screened against
erythromycin (Table 3.5). To further assess the morphological characteris-
tics of these isolates, they were cultured on Streptococcus salivarius/mitis
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agar (Table 3.5). A morphological representative of each of these isolates
was identified by sequencing the 16S gene, the bacterial species identified are
displayed on Table 3.6.
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Table 3.4: Minimum inhibitory concentration (MICs) of tetracycline and ery-
thromycin for isolates from saliva sample S2.
ID Tet (24h) Tet (48h) Erth (24h) Erth (48h)
S2-1 >256 >256 16 16
S2-2 >256 >256 16 16
S2-3 >256 >256 16 16
S2-4 >256 >256 16 16
S2-5 >256 >256 16 16
S2-6 >256 >256 16 16
S2-7 >256 >256 16 16
S2-8 >256 >256 16 16
S2-9 >256 >256 16 16
S2-10 128 128 8 8
S2-11 >256 >256 16 16
S2-12 >256 >256 16 16
S2-13 >256 >256 4 8
S2-14 128 128 2 4
S2-15 64 128 2 4
S2-16 64 128 2 8
S2-17 64 >256 16 16
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Table 3.6: The isolates were divided based upon the morphological factors that
were observed based upon culturing on different agar types. A morphological
representative from each of these types underwent PCR of the 16S gene which was
sequenced in order to determine the bacterial species.
ID Species (16S )
S28 1 Rothia dentocariosa
S28 2 Rothia dentocariosa
S28 6 Streptococcus sanguinis
S28 21 Streptococcus haemolyticus
S28 30 Neisseria subflava
S28 42 Streptococcus salivarius
3.4 Procedure Outline
The transposon aided capture of plasmids (TRACA) is a method for isolat-
ing plasmids that are present in bacteria without the need to first culture the
bacteria. Therefore this technique allows the capture of plasmids that are
located in bacteria that are not presently able to be cultured successfully un-
der laboratory conditions. TRACA was initially used by Jones and Marchesi
(Jones and Marchesi, 2007) to capture plasmids from human gut microbiota.
In this instance TRACA is being used to identify and characterise plasmids
that are present within the oral cavity of healthy human individuals.
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Figure 3.2: Diagram outlining the TRACA method from (Jones and Marchesi,
2007).
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3.5 Method
20µl of DNA was pooled from each saliva sample from S1 to S10 producing a
final volume of 200µl. The metagenomic DNA digested is shown in Table 3.7.
Approximately 600ng of pooled DNA was subsequently digested for 16 hours
using a plasmid safe DNase in order to remove linear DNA. The restriction
digest reaction is shown in table 3.8. 12.36µg was digested. Following diges-
tion the product was run through the QiaQuick Miniprep Kit (Qiagen) and
the remaining DNA was quantified using the Qubit (Invitrogen). The final
yield of DNA was 1.72ng/µl.
Table 3.7: Metagenomic DNA digested for TRACA procedure.
Sample ID ng DNA in 20ul Volume (µl)
S1 4960 20
S2 4600 20
S3 4040 20
S4 1820 20
S5 940 20
S6 2220 20
S7 720 20
S8 1360 20
S9 1400 20
S10 2660 20
TOTAL 24720 200
DNA ng/µl 123.6
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Table 3.8: Plasmid safe restriction digestion.
Reagent Concentration Negative control vol. Reaction volume
DNA 123.6ng/µl 5µl 100µl
ATP 25mM 0.5µl 10µl
Buffer 10x 1.25µl 25µl
Enzyme 10U/µl 0µl 5µl
ddH2O - 5.75µl 110µl
Total 12.5µl 250µl
Table 3.9: Reagents and volumes required for the TRACA reaction.
Reagent Concentration Volume
DNA 1.72ng/µl 10µl
Transposon 0.1pmol/µl 1µl
Transposase 1U/µl 2µl
ddH2O - 32µl
Buffer 10x 5µl
Total 50µl
3.5.1 TRACA Reaction
The TRACA reaction was set up as detailed in Table 3.9 and incubated at
37oC for 2 hours then stopped via the addition of 5µl of EzTn5 stop buffer
and incubated at 70oC for 15 minutes.
The plasmid is then purified using the QIAquick miniprep kit (Qiagen) in
accordance with the protocol supplied. The purified plasmid is then trans-
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formed into E. coli via electroporation by combining 4µl DNA with 50µl E.
coli EPI300 cells (Epicentre) and electroporated as described in Section 2.3.4.
Finally 100µl cells were spread onto an LB agar plate containing 50µg/ml
kanamycin.
3.6 Results
68 plasmids were captured in total. Restriction digest profiling using Sau3AI
revealed 32 different plasmid profiles, these were given a clone ID in the form
of “TRACAX”. 24 of these plasmids were taken forward for further analysis
(Table 3.10).
Table 3.10: The plasmids that were captured using TRACA were digested using
Sau3AI, profiles were established based upon the fragment sizes.
ID Fragment sizes Group Plasmid ID
TRACA1 2700, 1500, 800, 600 1 pSPW01
TRACA2 1800, 1500, 400, 200 11 pSPW11
TRACA3 1000, 700, 400, 200 15
TRACA4 1300, 700, 250 12 pSPW12
TRACA5 3000, 2250, 900, 850, 550, 500, 300, 250 17
TRACA6 1200, 550, 300, 250 2 pSPW02
TRACA7 1300, 700, 250 15
TRACA8 2250, 1500, 700, 500, 400, 350, 300 5
TRACA9 2000, 1300, 900 3 pSPW03
TRACA10 2250, 1500, 700, 500, 400, 350, 300 5
TRACA11 2000, 1400, 700, 550 19 pSPW20
TRACA12 2700, 1500, 800, 600 1
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ID Fragment sizes Group Plasmid ID
TRACA13 1400, 400, 200 25
TRACA14 600, 550, 400, 200 24
TRACA15 2500, 1000, 900, 600, 550, 350, 250 9
TRACA16 1000, 800, 200 27
TRACA17 1900, 20 pSPW21
TRACA18 2250, 1400, 600 13 pSPW14
TRACA19 2500, 1000, 900, 600, 550, 350, 250 9 pSPW09
TRACA20 1200, 600, 200 29
TRACA21 1000, 700, 400, 200 14 pSPW15
TRACA22 2000, 1400, 700, 550 19
TRACA23 1250,1200, 600, 300 15
TRACA24 1000, 900, 600, 350, 250 10 pSPW10
TRACA25 2500, 1000, 900, 600, 550, 350, 250 9
TRACA26 1450, 1400, 400, 250 18
TRACA27 1000, 600 28
TRACA28 1250,1200, 600, 300 15
TRACA29 1000, 700, 400, 200 14
TRACA30 1000, 700, 400, 200 14
TRACA31 1400, 300 26
TRACA32 1250,1200, 600, 300 15 pSPW16
TRACA33 2250, 1500, 700, 500, 400, 350, 300 5
TRACA34 1200, 600, 300 21 pSPW22
TRACA35 2250, 1400, 600 13
TRACA36 1000, 700, 400, 200 14
TRACA37 4000 4 pSPW04
TRACA38 2250, 1500, 700, 500, 400, 350, 300 5 pSPW05
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ID Fragment sizes Group Plasmid ID
TRACA39 3000, 2250, 900, 850, 550, 500, 300, 250 17
TRACA40 1200, 600, 300 21
TRACA41 2250, 1500, 700, 500, 400, 350, 300 5
TRACA42 2250, 1500, 700, 500, 400, 350, 300 5
TRACA43 1000, 600 28
TRACA44 700, 500, 400 30
TRACA45 3000, 2250, 900, 850, 550, 500, 300, 250 17
TRACA46 2250, 1500, 700, 500, 400, 350, 300 5
TRACA47 900, 800, 250 31
TRACA48 1100,1000, 600, 250 16 pSPW17
TRACA49 3000, 2250, 900, 850, 550, 500, 300, 250 17 pSPW18
TRACA50 900, 650, 250 32
TRACA51 1450, 1400, 400, 250 18 pSPW19
TRACA52 3000, 2250, 900, 850, 550, 500, 300, 250 17
TRACA53 1200, 600, 300 21
TRACA54 2250, 1500, 700, 500, 400, 350, 300 5 pSPW07
TRACA55 3200, 2000, 1200, 550, 500, 250 8 pSPW08
TRACA56 3000, 2250, 900, 850, 550, 500, 300, 250 17
TRACA57 250, 400, 600, 1000, 1500, 3500, 4500 22
TRACA58 2000, 1400, 700, 550 19
TRACA59 250, 400, 600, 1000, 1500, 3500, 4500 22
TRACA60 3000, 2250, 900, 850, 550, 500, 300, 250 17
TRACA61 2250, 1500, 700, 500, 400, 350, 300 5
TRACA62 1400, 300 26
TRACA63 1450, 1400, 400, 250 18
TRACA64 1000, 700, 400, 200 14
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ID Fragment sizes Group Plasmid ID
TRACA65 1000, 700, 400, 200 14
TRACA66 250, 400, 600, 1000, 1500, 3500, 4500 22 pSPW23
TRACA67 2250, 1500, 700, 500, 400, 350, 300 5
TRACA68 1200, 1500 23 pSPW24
There were 19 plasmids that were successfully sequenced, these are pre-
sented in Figures 3.3 to 3.18 and Tables 3.13 to 3.28, a summary of the
plasmids is presented in Table 3.11. These plasmids ranged from 780 to
5579 bp in size. The bacterial species that each plasmid originated from
was determined by comparing the sequence of the origin of replication with
the NCBI database. Based on this the plasmids appear to have originated
from Streptococcus agalactiae (n = 8), Streptococcus pneumoniae (n = 2),
Staphylococcus aureus (n = 2), Neisseria gonorrhoeae (n = 1) with 6 being
unidentified. Antibiotic resistance genes were identified on 11 of the plas-
mids, the most common being β-lactamase belonging to the TEM family (n
= 8). Other antibiotic resistance genes identified included chloramphenicol
acetyltransferase (n = 3) and aminoglycoside phosphotransferase (n = 3).
The activity of these genes was assessed via MIC testing shown below. The
MIC data (Table 3.12) suggests that the β-lactamase and chloramphenicol
acetyltransferase genes that are being carried by these plasmids are active. It
was not possible to determine the functionality of the aminoglycoside phos-
photransferase gene due to the presence of the kanR gene on the Ez-Tn5
transposon present in the plasmid.
In addition to antibiotic resistance genes, a number of ORFs were identi-
fied, comparison with the NCBI database revealed that the majority of these
ORFs were hypothetical proteins the function of which is currently unknown.
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3.6.1 Similarity with Cloning Vectors
Nine of the plasmids sequenced appeared to share features with a variety of
cloning vectors, including antibiotic resistance genes and β-galactosidase.
3.7 Antibiotic Resistance Activity
Table 3.12: The plasmids captured via TRACA underwent MIC testing with
Ampicillin and chloramphenicol. All had an MIC greater than 512 µg/ml with
the exception of pSPW08 which was 32 µg/ml. The dashes refer to clones that
were sensitive to the antibiotic showing no signs of resistance. The negative control
strain used was Bacillus subtilis CU2189 that is known to be sensitive to ampicillin
and chloramphenicol.
Plasmid ID Ampicillin µg/ml Chloramphenicol µg/ml
pSPW01 >512 -
pSPW02 >512 -
pSPW05 >512 16
pSPW06 >512 16
pSPW08 32 -
pSPW09 >512 8
pSPW18 >512 -
pSPW23 >512 -
84
3.8 Annotated Plasmids
Figure 3.3: pSPW01 contains ORFs that match with a TEM family β-lactamse,
however the functionality of this could not be assessed because the transposon
appears to have inserted within this sequence.
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Table 3.13: The ORFs identified on pSPW01 as shown in Fig. 3.3, their closest
homologues and the species that the ORF originated from where applicable.
ORF Location Closest homologue QC% ID% Species
3988 - 399 c TEM Class A β-lactamase 99 99
733 – 1116 c LacZ 82 96
1374 – 2318 c RepC 99 88 S. pneumoniae
3063 – 3371 c Hypothetical protein 85 93
3129 – 3554 Hypothetical protein 98 100
3428 – 3736 Hypothetical protein 91 99
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Figure 3.4: This plasmid contains a β-lactamase gene from the TEM family, this
gene has 98% query cover of TEM-1. Other ORFs partially match hypothetical
proteins, one of which is originally from Bacillus cereus, there was no origin of
replication detected on this plasmid.
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Table 3.14: The closest homologues to the ORFs identified in pSPW02 as shown
in Fig. 3.4, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC % ID % Species
3-875 TEM β-lactamase 98 100
479-790 c Unknown (CV) 85 100
995 -1300 Hypothetical protein 89 100
1127-1405 c Hypothetical protein 91 99
1309-1737 c Hypothetical protein 78 100
1553-1879 c Hypothetical protein 67 100 Bacillus cereus
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Figure 3.5: Plasmid pSPW05 contains two antibiotic resistance genes, a β-
lactamase from the TEM family and chloramphenicol acetyltransferase, both of
these genes were shown to confer resistance in the clonal host. ORFs also matched
hypothetical proteins from a range of species and an origin of replication from S.
aureus suggesting that the plasmid originated from this species.
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Table 3.15: The closest homologues to the ORFs identified in pSPW05 as shown
in Fig. 3.5, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC % ID % Species
213 - 596 c LacZ 82 96
854 - 1798 c Rep initiation protein 99 100 S. aureus
1694 - 2026 Hypothetical protein 94 96 S. aureus
2234 - 2896 Chloramphenicol acetyltransferase 98 100 Multispecies
3676 - 3984 c Hypothetical protein 99 83 E. coli
3742 - 4167 Uncharacterised protein 94 97 Y. pseudoterberculorosis
4071 - 4349 Hypothetical protein 91 99 Multispecies
4176 - 4481 c Hypothetical protein 89 100
4601 - 5473 c TEM β-lactamase 98 100
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Figure 3.6: A TEM family β-lactamase and chloramphenicol acetyltransferase were
identified on pSPW06, both of these genes conferred resistance in their hosts. An
origin of replication originating from S. aureus was identified.
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Table 3.16: The closest homologues to the ORFs identified in pSPW06 as shown
in Fig. 3.6, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
159-467 c Hypothetical protein 99 82 E. coli
225-650 Hypothetical protein 98 99
554-832 Hypothetical protein 91 99 Enterobacteriaceae
659-964 c Hypothetical protein 89 100
1084-1956 c TEM β-lactamase 98 100
2290-2673 c LacZ 82 96
3010-3876 c Replication protein 98 99 S. aureus
4313-4954 Chloramphenicol acetyltransferase 97 99
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Figure 3.7: The ORFs on pSPW08 matched a TEM family β-lactamase as well
as ORFs predicted to encode hypothetical proteins that have been detected in
a variety of species. A lacZ gene was also detected. There was no origin of
replication detected on this plasmid. Growth on CLED agar and revealed that the
ORF identified as lacZ was not functional.
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Table 3.17: The closest homologues to the ORFs identified in pSPW08 as shown
in Fig. 3.7, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC % ID % Species
394-669 Hypothetical protein 82 100
496-774 c Hypothetical protein 91 99 Multispecies
678-1103 c Hypothetical protein 98 100
861-1169 Hypothetical protein 99 83 E. coli
2824-3207 LacZ 82 96
3451-4154 c TEM β-lactamase 98 100
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Table 3.18: The closest homologues to the ORFs identified in pSPW09 as shown
in Fig. 3.8, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
225 – 650 Hypothetical protein 98 100 Neospora caninum
554 – 880 Hypothetical protein 94 83 Enterobacteriae
707 – 1012 c Hypothetical protein 89 100 Parasitella parasitica
1158 – 1994 c β-lactamase TEM-1 91 94
2219 – 2653 LacZ 86 70
2931-3875 c Replication protein 100 97 S. pneumoniae
4312 -4974 Chloramphenicol acetyltransferase 98 100
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Figure 3.8: The closest homologues to the ORFs on pSPW09 were predicted to
encode hypothetical proteins from a variety of species and a β-lactamase gene from
the TEM family that conferred resistance to the host bacteria. In addition to this
a lacZ gene was identified though the sequence homology was only 70% with a
query cover of 86%. Growth on CLED agar revealed that the ORF identified as
lacZ was not functional.
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Figure 3.9: The ORFs on pSPW10 that most closely matched ORFs encoding
hypothetical proteins originated from Streptococcus species. A potential origin of
replication from Streptococcus agalactiae was detected, however the % ID was only
51%.
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Table 3.19: The closest homologues to the ORFs identified in pSPW10 as shown
in Fig. 3.9, their query cover and identity match % and the species that they
originated from where applicable.
OEF Location Closest homologue QC% ID% Species
1- 373 c Hypothetical protein 58 36 Streptococcus gallolyticus
604 – 1011 c Hypothetical protein 69 33 Streptococcus suis
1119 – 1508 c Hypothetical protein 93 61 Streptococcus parasanguinis
1788 – 2945 c Replication protein 98 51 Streptococcus agalactiae
3213 – 3542 c Hypothetical protein 85 29
3611 – 4443 c Hypothetical protein 94 38
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Figure 3.10: An origin of replication that most closely resembled an ori from
Streptococcus agalactiae was detected along with ORFs that matched sequences
predicted to encode hypothetical proteins.
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Table 3.20: The closest homologues to the ORFs identified in pSPW11 as shown
in Fig. 3.10, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC % ID % Species
227-625 c Hypothetical protein 85 98
281-1006 Replication protein 96 99 S. agalactiae
1033-1380 c Lysine decarboxylase 53 40 Comamonas spp.
1037 – 1318 Hypothetical protein 50 98
1135-1410 Hypothetical protein 45 93
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Figure 3.11: pSPW12 contains ORFs that most closely match sequences that are
predicted to encode hypothetical proteins, however the sequence homology for all
three of these proteins is relatively low. Two of the ORFs most closely match
sequences from S. agalactiae suggesting that this plasmid may have originated in
this species.
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Table 3.21: The closest homologues to the ORFs identified in pSPW12 as shown
in Fig. 3.11, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC % ID % Species
494-1246 Hypothetical protein 84 98 S. agalactiae
520-879 Hypothetical protein 21 73 S. agalactiae
578-865 c Hypothetical protein 68 91
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Figure 3.12: pSPW15 contained open reading frames that most closely matched
sequences that are predicted to encode hypothetical proteins.
Table 3.22: The closest homologues to the ORFs identified in pSPW15 as shown
in Fig. 3.12, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
217 – 501 c Hypothetical protein 90 100
934 – 1227 c Hypothetical protein 67 58
1823 – 2308 Replication protein 86 98 Neisseria gonorrhoeae
2604 – 2981 c Hypothetical protein 29 65
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Figure 3.13: The ORFs on pSPW18 most closely resembled sequences that were
predicted to encode hypothetical proteins and a TEM family β-lactamase that was
shown to confer resistance to the clones. Growth on CLED agar revealed that the
ORF identified as lacZ was not functional.
Table 3.23: The closest homologues to the ORFs identified in pSPW18 as shown
in Fig. 3.13, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
212 – 637 Hypothetical protein 98 100 Thermoanaerobacter
646 - 951 c Hypothetical protein 89 100
1071 – 1943 c TEM β-lactamase 98 100
2277 – 2660 c LacZ 82 96
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Figure 3.14: Three ORFs were detected on pSPW19, the closest homologues were
sequences predicted to encode hypothetical proteins, and an origin of replication
from S. agalactiae.
Table 3.24: The closest homologues to the ORFs identified in pSPW19 as shown
in Fig. 3.14, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC % ID % Species
299-697 c Hypothetical protein 85 98
353-1078 Replication protein 96 99 S. agalactiae
1109-1476 Hypothetical protein 38 77
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Figure 3.15: Two open reading frames were identified on pSPW21, these included
an origin of replication from S. agalactiae. The closest match to the other ORF
was a sequence predicted to encode a hypothetical protein however both the query
cover and maximum identity percentages were low.
Table 3.25: The closest homologues to the ORFs identified in pSPW21 as shown
in Fig. 3.15, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
123 – 725 Replication protein 93 98 Streptococcus agalactiae
880 – 1293 Hypothetical protein 42 79
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Figure 3.16: pSPW22 contained ORFs that most closely matched an origin of
replication from S. agalactiae however the query cover is relatively low. The other
closest matches were sequences predicted to encode hypothetical proteins, one of
which from S. agalactiae. No origins of replication were detected in this sequence.
Table 3.26: The closest homologues to the ORFs identified in pSPW22 as shown
in Fig. 3.16, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
455 – 880 Replication protein 91 96 Streptococcus agalactiae
714 – 1181 Hypothetical protein 72 97 Streptococcus agalactiae
1212 – 1502 Hypothetical protein 27 96
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Figure 3.17: The ORFs on pSPW23 were most closely matched to sequences pre-
dicted to encode hypothetical proteins from Erwinia amylovora and Escherichia
coli. A TEM familyβ-lactamase was also detected that conferred resistance to the
host clone. No origin of replication was detected on this sequence.
Table 3.27: The closest homologues to the ORFs identified in pSPW23 as shown
in Fig. 3.17, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
1 – 357 Hypothetical protein 100 100 Erwinia amylovora
261 – 539 Hypothetical protein 91 99 Escherichia coli
366 – 671 c Hypothetical protein 89 100
791 – 1663 c TEM β-lactamase 100 99
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Figure 3.18: The two open reading frames on pSPW24 were most closely related
to sequences predicted to encode a hypothetical protein, and lysine carboxylase.
No origins of replication were detected in this sequence.
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Table 3.28: The closest homologues to the ORFs identified in pSPW24 as shown
in Fig. 3.18, their query cover and identity match % and the species that they
originated from where applicable.
ORF Location Closest homologue QC% ID% Species
109-423 c Hypothetical protein 56 98
175-525 Lysine carboxylase 53 40 Comamonas spp.
3.8.1 Comparison of TEM β-lactamase Genes
The TEM class β-lactamase genes were compared using Clustal Omega align-
ment. The alignment shows a high degree of similarity between the resistance
genes. The β-lactamase gene belongs to the transpeptidase superfamily and
is identified as TEM-116, a variant of TEM-1. Clustal Omega analysis re-
vealed that there are single nucleotide polymorphisms (SNPs) in this gene
compared with TEM-1. These substitutions include a T − C substitution at
position 18, a T − substitution at position 228, a G − A substitution at po-
sition 244 a T − G substitution at position 396 and a C − T substitution at
position 545. The majority of these substitutions are silent having no impact
upon the amino acid sequence of the encoded protein with the exception of
a A - V (alanine to valine) substitution which occurs at position 182 on the
protein.
3.8.2 LacZ Genes
Five of the plasmids captured contained ORFs of which the closest homologue
in the NCBI database was lacZ. The functionality of this gene was determine
by culturing the clones on Cystine-lactose-electrolyte-deficient agar (CLED)
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agar. In all cases the lacZ gene appeared to be non-functional.
3.8.3 Comparison of Origins of Replication
BLAST analysis revealed known origins of replication on 4 plasmids 3 of
these were identified as RepC and one as RepB, in addition putative origins
of replication were identified on 5 plasmids showing similarity to the Rep 2
superfamily.
3.9 Discussion
3.9.1 TEM β-lactamase
TEM β-lactamase is a Class A β-lactamase (Cooksey et al., 1990), that
confers resistance to penicillins and early cephlosporins by hydrolysing the
β-lactam ring (Salverda et al., 2010). It is commonly observed in Gram
negative bacteria. This enzyme was first observed in E. coli in 1965 (Datta
and Kontomichalou, 1965). The presence of this antibiotic resistance gene
on plasmids in oral bacteria may have an impact on treatment as penicillin
antibiotics are widely used as a first line of treatment in oral infections. Over
100 unique variants of TEM upbeta-lactamase have been identified (Zeil et al.,
2016).
3.9.1.1 TEM-116
TEM-116 was first identified in the 1990s and has been described as occurring
in a variety of Gram negative isolates and is present on conjugative plasmids
that vary in size (Lahlaoui et al., 2011; Maravic´ et al., 2016). The defining
mutations in TEM-116 are V82I and A184V (Hu et al., 2007). These muta-
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tions lie in chains separate from the active site. In the 1980s, blaTEM-1 was
engineered to contain these mutations in order to remove PstI and HincII
restriction sites (Jacoby and Bush, 2016). The sequences of some reported
blaTEM-116 genes, are identical to the synthetically constructed pUC vectors
(Jacoby and Bush, 2016). This is the case with the sequences identified in
this study. A potential problem arises here, as there have been commer-
cial Taq polymerase PCR kits that were shown to have been contaminated
with exogenous DNA containing blaTEM-116 which has lead to the erroneous
reporting of blaTEM-116 in S. pneumoniae (Koncan et al., 2007). A recent
study investigating TEM β-lactamases identified over 50 derivatives from
TEM-116 (Zeil et al., 2016). The majority of these derivatives contain both
of mutations associated with TEM-116 with the exception of TEM-171 which
contains only the V82I mutation and TEM-181 which contains the A184V
mutation. These two genes may be intermediate evolutionary steps between
TEM-1 and TEM-116. Therefore despite the concern of erroneous reporting
of TEM-116 due to contaminated reagents the centrality of TEM-116 within
the TEM family network, as well as its wide geographical distribution and
establishment on multiple plasmids suggest that TEM-116 is now a naturally
occurring enzyme (Jacoby and Bush, 2016).
3.9.2 Chloramphenicol acetyltransferase
This is an enzyme that confers resistance to the antibiotic chloramphenicol.
The gene that encodes this enzyme is often present on R-plasmids (Shaw and
Cabelli, 1980). A diverse range of bacteria have been observed producing this
enzyme as well as yeasts such as Streptomyces spp. Resistance to chloram-
phenicol is clinically important as chloramphenicol is listed as “essential” by
the World Health Organisation (WHO). The antibiotic chloramphenicol is
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able to cross the blood brain barrier effectively as such, chloramphenicol is
used in the treatment of bacterial meningitis. The presence of plasmids in
the oral cavity carrying this resistance gene could have serious consequences
for individuals who develop bacterial meningitis, especially bacteria that typ-
ically reside in the oral cavity have the potential to cause this disease. For
example, Streptococcus tigurinus a novel species of oral bacteria identified in
2012 is associated with invasive infections such as meningitis (Zbinden et al.,
2012, 2015).
3.9.3 Species of Origin
3.9.3.1 Staphylococcus aureus
The plasmids where an origin of replication had been identified appear to
have originated in bacteria that are typically resident in the oral cavity.
Staphylococcus aureus has long been known to reside in the oral cavity how-
ever it is often overlooked as a causal agent of oral infection (McCormack
et al., 2015). Staphylococcus aureus isolation rates vary between different
populations and have been reported to range from 24% to 84% in the healthy
population (Jackson et al., 1999; Ohara-Nemoto et al., 2008) Staphylococcus
aureus is associated with mucosal disease that may be caused by endotoxins
that are secreted by various strains (McCormack et al., 2015). The presence
of a variant of TEM-1 on plasmids suggests that there is a plasmid mediated
reservoir of β-lactam resistance in the oral cavity. TEM-1 provides resistance
to amoxicillin. Amoxicillin is the often the first treatment prescribed follow-
ing dental infection, as such an amoxycillin resistant infection could effect
the treatment that is prescribed. For example treatment with the later gen-
eration penicillin methicillin may be required, which would create a positive
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selection pressure favouring resistance to methicillin.
Between 1998 and 2007 the prevalence of MRSA within the oral cavity was
investigated, the authors found that for the period ranging between 1998-
2007, across 11,312 samples. The results showed that 18% of the infections
were caused by S. aureus, 10% of which were identified as being methicillin
resistant. The disease state most commonly reported in the case of S. aureus
was angular cheilitis, erythmea and swelling were reported in both MRSA
and MSSA (McCormack et al., 2015). The recovery of MRSA from oral
samples taken from patients in a community rather than hospital setting
reinforces that MRSA is not restricted to the typically cited body niches of
the preineum, throat and nose and highlights the importance of infection
control procedures for all patients (McCormack et al., 2015).
The data generated in this study reveals that there is a plasmid containing
a TEM-1 β-lactamase gene, however in the absence of transferability studies
it is not possible to say whether this plasmid is capable of transferring be-
tween different bacteria. Rep protein analysis of pSPW05 indicates that this
plasmid originated from S. aureus, in addition to the TEM-1 gene conferring
resistance to β-lactam antibiotics, this plasmid also contains a gene encoding
chloramphenicol acetyltransferase. This is of interest because a study was
carried out in 2013 assessing the effectiveness of chloramphenicol in the treat-
ment of S. aureus (Fayyaz et al., 2013). This study tested 174 MRSA isolates
for chloramphenicol susceptibility, revealing that 132 (75.86%) of the isolates
were susceptible (Fayyaz et al., 2013). The authors conclude that chloram-
phenicol has demonstrated good in vitro against S. aureus and is likely to
contribute to the treatment of S. aureus by providing an effective alternative
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to expensive antimicrobials in countries where resources are limited (Fayyaz
et al., 2013). The presence of a plasmid carrying genes that confer resistance
to β-lactam antibiotics and chloramphenicol could present problems in such
a situation by limiting the effectiveness of chloramphenicol as an alternative
treatment.
3.9.3.2 Streptococcus pneumoniae
Analysis of the origin of replication from pSPW09 revealed that this plasmid
likely originated from the species Streptococcus pneumoniae. Streptococcus
pneumoniae is an opportunistic pathogen that typically resides in the up-
per respiratory tract such as the nasopharynx and oral cavity. Streptococ-
cus pneumoniae is an opportunistic pathogen, infection is asymptomatic in
healthy carriers however it can cause a variety of serious disease states in
individuals who are immunocompromised. The most serious conditions that
are caused by this bacteria are pneumonia, meningitis, sepsis, pericarditis,
endocarditis and brain abscess (Deutscher et al., 2011).
The presence of pSPW09, a plasmid from Streptococcus pneumoniae that
confers resistance to β-lactam antibiotics and chloramphenicol is of concern
because of the virulence of this species of bacteria as well as the fact that
this plasmid was found in metagenomic DNA from individuals who have not
taken any antibiotic treatment recently therefore suggesting that this plas-
mid is present within the healthy population in the absence of any obvious
selection pressure thereby suggesting that this plasmid is part of the stable
reservoir of mobile elements that carry antibiotic resistance genes.
115
3.9.3.3 Streptococcus agalactiae
Streptococcus agalactiae are typically resident in the oral cavity as well as
the gastrointestinal tract. In the majority of cases this species is commen-
sal however in immunocompromised individuals Streptococcus agalactiae can
become an opportunistic pathogen.
Of the plasmids where an origin of replication was identified, the major-
ity originated from Streptococcus agalactiae (n = 5). No antibiotic resis-
tance genes were identified on the plasmids that originated from Streptococ-
cus agalactiae. However there were a number of ORFs predicted to encode
hypothetical proteins of unknown function, it is possible that these proteins
confer a selective advantage to the host bacteria containing these plasmids.
3.9.3.4 Neisseria gonorrhoeae
The origin of replication of plasmid pSPW15 appears to have originated in
Neisseria gonorrheae. Neisseria gonorrhoeae is a pathogenic bacteria, it is
not typically resident within the oral cavity however it has been observed to
cause oral infections. Other species of Neisseria are typical inhabitants of
the oral cavity so it is possible that this plasmid was transferred to one of
these species from Neisseria gonorrhoeae. It is also possible that the plasmid
pSPW15 did not originate from Neisseria gonorrhoeae as the query cover in
BLAST analysis was only 86%.
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3.9.4 Plasmids Captured in Comparison to other TRACA
Studies
3.9.4.1 Gut Metagenome
The plasmids that were captured from the human gut metagenome (Jones
and Marchesi, 2007) appeared to be quite different in character to the plas-
mids that have been identified in this study. The plasmids identified from
the gut metagenome were speculated to be from Bacillus cereus, Bacillus
licheniformis, Lactobacillus acidophilus, Selenomonas ruminatium, Bacillus
thuringenesis and Campylobacter jejuni.
3.9.4.2 Dental Plaque from Periodontal Patients
Another study (Warburton et al., 2011), used TRACA to capture plasmids
from patients who were suffering from periodontal disease. Dental plaque
was sampled as opposed to saliva as in this study. The authors found a
variety of plasmids that contained putative origins of replication that are
likely to come from multiple species. The species that the plasmids originated
within is different to those that were captured during the course of this
research with the exception of Neisseria gonorrhoeae. Interestingly, none of
the plasmids that were identified in (Warburton et al., 2011) were predicted
to be of Streptococcal origin as Streptococcus spp. in particular Streptococcus
mutans is known to be an important participant in the development of dental
plaque. It seems unusual that plasmids of streptococcal origin would be
captured from saliva but not from plaque, this could be due to the difference
in the DNA extraction techniques that were employed by the two studies,
in this method the FastPrep (MP Bio) homogenizer is considerably more
violent than the enzyme based DNA extraction that was employed on the
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dental plaque samples (Warburton et al., 2011). Streptococcus spp. have a
thick cell wall that is difficult to lyse.
Of the plasmids captured, 6 belong to the pTRACA42 group that was first
identified in dental plaque (Warburton et al., 2011). This group of plasmids
appears to be common within the oral cavity and were the most common
group of plasmids captured from both dental plaque from patients (Warbur-
ton et al., 2011) and saliva samples from healthy individuals. No antibiotic
resistance genes have been identified on any of the plasmids that belong to
this group on either study.
3.10 Conclusions
This research demonstrates that the TRACA system may be used to capture
plasmids from bacteria in the oral metagenome. The presence of plasmids
that contain antibiotic resistance genes in the absence of antibiotic selection
pressure suggests that it is possible that there is another advantage that
these plasmids are offering their bacterial hosts in addition to antibiotic re-
sistance. It is likely that such an advantage is conferred by one of the ORFs
identified. These results demonstrate that there is plasmid involvement in
the maintenance of a reservoir of antibiotic resistance genes in commensal
bacteria. The plasmids captured from saliva samples during this study had a
greater homology to the plasmids that were captured via TRACA from the
plaque from periodontal patients than those that were captured from the gut
metagenome, this is not surprising due to the proximal relationship between
where the samples were gathered from.
The plasmid group pTRACA42 appears to be common within the oral envi-
ronment, to date this group of plasmids has not been observed in any other
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setting. The pTRACA42 group appears to be both common in healthy and
infected individuals, to date the pTRACA42 group have not been shown to
harbour any genes that confer resistance to antibiotics.
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Chapter 4
Bacteria Isolated from Swabs of
Infected Wounds
4.1 Antibiotic Resistance in a Clinical Set-
ting
4.1.1 Rationale
This section of research investigates the presence of antibiotic resistance genes
and genes that are associated with mobile genetic elements in samples that
have been obtained from within a clinical setting. The focus of this study is
on tetracycline, erythromycin and vancomycin resistance. Additional work
was carried out on methicillin regarding the isolates that were identified as
Staphylococcus aureus.
Transposons are modular, the modules that they contain can be interchanged
and replaced with other modules, therefore as the modules within the trans-
poson are acquired and/or lost, they can acquire resistance to additional
antibiotics, potentially resulting in multiple resistance genes being located
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upon one mobile element.
4.1.2 Bacteria in Wounds
Bacteria that compose the skin flora often colonise wounds. Limitations in
what bacterial species are culturable in the laboratory have historically led
to a misrepresentation of what species are present on the skin flora with S.
aureus and S. epidermis thought to be the most dominant species due to
their being relatively easy to culture. Analysis of 16S rRNA has revealed
that the diversity of bacterial species that inhabit the skin is greater than
originally thought (Cogen et al., 2008; Grice et al., 2008). Wounds support
communities of both anaerobic and aerobic bacteria, these bacteria may ini-
tiate infections or establish a less invasive relationship with the host (Cooper
et al., 2009). The development of infection in wounds typically results from
either an increased host susceptibility or an increase in bacterial load or vir-
ulence (Cooper, 2005). Bacteria that frequently reside within the skin flora
and their pathogenicity are shown in Table 4.1.
Should a break in the skin occur forming a wound, the bacteria belonging to
the skin flora may enter the wound. The quantity of bacteria that enter the
wound impacts upon infection and the healing rate of the wound, the effect
of the microbial load on wound healing was first identified when healing in
decubitus ulcers only progressed when the bacterial load was less than 106
CFU/ml of wound fluid (Bendy and Landman, 1964). As well as microbial
load wound healing is also affected by the differences between the specific
species present (Bowler et al., 2001). Species that have been reported to have
the most detrimental effect on wound healing are S. aureus, P. aeuriginosa
and β-haemolytic streptococci (Bowler et al., 2001; Danielsen et al., 1998).
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Table 4.1: Frequently studied bacteria that reside as part of the skin flora and
their pathogenicity.
Species Pathogenicity
Staphylococcus aureus Typically pathogenic
Staphylococcus epidermis Occasionally pathogenic
Staphylococcus warneri Occasionally pathogenic
Streptococcus mitis Occasionally pathogenic
Streptococcus pyogenes Typically pathogenic
Propionibacterium acnes Occasionally pathogenic
Pseudomonas aeuriginosa Occasionally pathogenic
Acdenitobacter johnsonii Occasionally pathogenic
Corynebacterium spp. Occasionally pathogenic
4.1.2.0.1 Acute vs Chronic Wounds The bacterial species that colonise
wounds tends to differ based on the length of time that the wound has been
present, the early colonisers tend to be Gram positive bacteria that are able
to grow in aerobic conditions such as Staphylococcus and Streptococcus. As
time progresses anaerobic bacteria also colonise the wound, these are typi-
cally acquired from exogenous sources such as bathwater (Dow et al., 1999).
Chronic wounds, such as ulcers provide a polymicrobial environment where
the exchange of genetic information is able to take place between bacteria.
This creates conditions whereby the transfer of a resistance gene to a new
species is more favourable, for example the first two cases of S. aureus resis-
tant to vancomycin were isolated from chronic wound patients (Howell-Jones
et al., 2005). A recent study investigating the bacteria that are found in
wounds observed that the most common species present is S. aureus, fol-
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lowed by P. aeruginosa (Wong et al., 2015).
4.1.3 Overview of Study
136 bacterial isolates have been received from different anatomical sites (Ta-
ble 4.4 and 4.5), the isolates that were suspected to belong to the strepto-
coccal or staphylococcal species were initially screened for resistance to the
antibiotics tetracycline and erythromycin at concentrations of 4µg/ml, those
isolates that were resistant to at least one of these antibiotics were taken
forward for further analysis. These isolates are presented in Table 4.6. The
isolates that were suspected of being enterococci were screened for resistance
to the antibiotic vancomycin at a concentration of 4µg/ml. Vancomycin re-
sistant isolates were taken forward for further analysis, these isolates are also
presented in Table 4.6.
4.2 Methods
4.2.1 Inverse PCR
The DNA was digested with the restriction enzyme BamHI, this enzyme
was selected because it does not cut the tetW gene (Table 4.2). Following
digestion The fragments were ligated (Table 4.3) to produce circular DNA.
Primers facing out off the end of the tetW gene were used to amplify the
regions which flank the gene, the primer sequences were tetW Fx: CTC TTA
CAC CAA CGG GCA GAG and tetW Rx: TGG CAT ATA GCA GGC TCT
CCG (this study).
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Table 4.2: BamHI digestion reaction, the reaction mix was incubated at 37◦C for
15 minutes.
Reagent Volume (µl) Stock Conc. Final Conc.
Buffer 1.5 10x 1x
BamHI 1 10U/µl 0.67U/µl
DNA 10 variable variable
ddH2O 2.5 − −
Total 15 − −
Table 4.3: Ligation reaction for the circularisation of digested DNA, the mix was
incubated at 25◦C for 15 minutes.
Reagent Volume (µl) Stock Conc. Final Conc.
ddH2O 8 − −
Buffer 10 2x 1x
DNA 1 variable variable
T4 ligase 1 3U/µl 0.15U/µl
Total 20 − −
4.2.2 Species Received from Queen Elizabeth Hospital
The wounds of patients being treated at the Queen Elizabeth hospital were
swabbed and the bacteria from the swab cultured. These cultures were trans-
ferred to agar slopes and transported to the laboratory for analysis.
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Table 4.4: Anatomical site of isolation and strain species information obtained via
biochemical testing carried out by the Queen Elizabeth hospital.
Number Species Date collected Site collected
QE01 Staphylococcus aureus 07/01/13 Groin swab
QE02 Staphylococcus aureus 07/01/13 Leg swab
QE03 Staphylococcus aureus 07/01/13 Thumb swab
QE04 Staphylococcus aureus 07/01/13 Toe swab
QE05 Staphylococcus aureus 07/01/13 Genital swab
QE06 Staphylococcus aureus 07/01/13 Wound swab - site not stated
QE07 Staphylococcus aureus 07/01/13 Wound swab left thigh
QE08 Staphylococcus aureus 07/01/13 Ulcer swab
QE09 Staphylococcus aureus 07/01/13 Wound swab foot
QE10 Staphylococcus aureus 07/01/13 Wound swab leg
QE11 Staphylococcus aureus 07/01/13 Wound swab arm
QE12 Staphylococcus aureus 08/01/13 Swab ear
QE13 Staphylococcus aureus 08/01/13 Wound swab knee
QE14 Staphylococcus aureus 08/01/13 Swab shin
QE15 Staphylococcus aureus 09/01/13 Swab umbilical cord
QE16 Staphylococcus aureus 09/01/13 Nephrostomy
QE17 Staphylococcus aureus 09/01/13 Wound swab line site
QE18 Staphylococcus aureus 09/01/13 Wound swab pilonidal
QE19 Staphylococcus aureus 09/01/13 Wound swab forearm
QE20 Staphylococcus aureus 09/01/13 Wound swab abdomen
QE21 Staphylococcus aureus 09/01/13 Ulcer swab foot
QE22 Staphylococcus aureus 08/01/13 Wound swab toe
QE23 Staphylococcus aureus 08/01/13 Wound swab finger
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Number Species Date collected Site collected
QE24 Staphylococcus aureus 08/01/13 Ulcer swab
QE25 Staphylococcus aureus 08/01/13 Genital swab penis
QE26 Staphylococcus aureus 10/01/13 Wound swab - site not stated
QE27 Staphylococcus aureus 09/01/13 Throat swab
QE28 Staphylococcus aureus 09/01/13 Head
QE29 Staphylococcus aureus 10/01/13 Ear swab
QE30 Staphylococcus aureus 10/01/13 Sputum
QE31 Staphylococcus aureus 10/01/13 Genital swab high vaginal
QE32 Staphylococcus aureus 10/01/13 Ulcer swab ankle
QE33 Staphylococcus aureus 10/01/13 Ulcer swab shin
QE34 Staphylococcus aureus 10/01/13 Swab arm
QE35 Staphylococcus aureus 10/01/13 Leg
QE36 Staphylococcus aureus 12/11/12 Urine
QE37 Streptococcus group A 13/11/12 Swab throat
QE38 Streptococcus group A 16/11/12 Wound swab
QE39 Streptococcus group A 11/01/13 Throat swab
QE40 Streptococcus group B 11/01/13 Genital swab high vaginal
QE41 Streptococcus group G 12/01/13 Pressure sore swab
QE42 Streptococcus group A 08/01/13 Genital swab high vaginal
QE43 Streptococcus group A 07/01/13 Throat swab
QE44 Streptococcus group A 07/01/13 Genital swab vulval
QE45 Streptococcus group B 11/11/12 Blood culture
QE46 Streptococcus group C 18/11/12 Blood culture
QE47 Staphylococcus aureus 28/11/12 Blood culture
QE48 Streptococcus group B 08/12/12 Blood culture
QE49 Streptococcus group B 11/12/12 Blood culture
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Number Species Date collected Site collected
QE50 Staphylococcus aureus 09/01/13 Nose swab
QE51 Streptococcus group A 07/01/13 Throat swab
QE52 Streptococcus group A 07/01/13 Ear swab
QE53 Streptococcus group A 07/01/13 Wound swab
QE54 Streptococcus group A 03/01/13 Genital swab high vaginal
QE55 Staphylococcus aureus 12/01/13 Would swab sacrum
QE56 Staphylococcus aureus 12/01/13 Wound swab Groshong line site
QE57 Streptococcus group A 19/12/12 Wound swab perianal
QE58 Streptococcus group A 27/12/12 Wound swab left arm
QE59 Streptococcus group A 17/12/12 Throat swab
QE60 Streptococcus group A 17/12/12 Ear swab
QE61 Streptococcus group A 18/12/12 Ear swab
QE62 Streptococcus group A 18/12/12 Throat swab
QE63 Streptococcus group A 11/12/12 Throat swab
QE64 Streptococcus group A 13/12/12 Throat swab
QE65 Streptococcus group A 20/12/12 Gastrostomy site swab
QE66 Streptococcus group A 20/12/12 Throat swab
QE67 Streptococcus group A 06/12/12 Foreskin swab
QE68 Streptococcus group A 07/12/12 Genital swab penis
QE69 Staphylococcus aureus 07/12/12 Sputum
QE70 Staphylococcus aureus 07/12/12 Nose swab
QE71 Streptococcus group A 28/11/12 Nose swab
QE72 Streptococcus group A 30/11/12 Ear swab
QE73 Streptococcus group A 29/11/12 Throat swab
QE74 Streptococcus group A 04/12/12 Sub-phrenic swab
QE75 Streptococcus group A 26-/11/12 Ear swab
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Number Species Date collected Site collected
QE76 Streptococcus group A 26/11/12 Throat swab
QE77 Streptococcus group A 27/11/12 Pus swab
QE78 Streptococcus group A 26/11/12 Throat swab
QE79 Streptococcus group A 22/11/12 Wound swab
QE80 Streptococcus group A 22/11/12 Nose swab
QE81 Streptococcus group A 23/11/12 Ear swab
QE82 Staphylococcus aureus 14/01/13 Breast aspirate
QE83 Staphylococcus aureus 14/01/13 Wound swab
QE84 Staphylococcus aureus 14/01/13 Ulcer swab
QE85 Staphylococcus aureus 14/01/13 Wound swab leg
QE86 Staphylococcus aureus 14/01/13 Ulcer swab toe
QE87 Streptococcus group A 14/01/13 Throat swab
QE88 Streptococcus group A 14/01/13 Ear swab
QE89 Streptococcus group B 14/01/13 PEG site swab
QE90 Streptococcus group G 14/01/13 Sputum
QE91 Streptococcus group G 14/01/13 Wound swab leg
QE92 Streptococcus Group B 16/05/2013 Swab leg
QE93 Streptococcus Group G 20/05/2013 Wound swab leg
QE94 Streptococcus Group G 09/05/2013 Wound swab leg
QE95 Streptococcus Group G 10/05/2013 Wound swab leg
QE96 Streptococcus Group B 08/05/2013 Genital swab high vaginal
QE97 Streptococcus Group G 20/05/2013 Wound swab
QE98 Streptococcus Group B 07/05/2013 Genital swab high vaginal
QE99 Streptococcus Group G 16/05/2013 Ulcer swab left leg
QE100 Streptococcus mitis/oralis 13/05/2013 Blood culture
QE101 Streptococcus Group G 09/05/2013 Ulcer swab right hallux
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Number Species Date collected Site collected
QE102 Streptococcus Group B 08/05/2013 Swab ear
QE103 Streptococcus Group B 14/05/2013 Genital swab high vaginal
QE104 Streptococcus Group G 17/05/2013 Blister swab ankle
QE105 Streptococcus Group G 13/05/2013 Ulcer swab leg
QE106 Streptococcus Group G 07/05/2013 Ulcer swab ankle
QE107 Streptococcus Group G 07/05/2013 Ulcer swab toe
QE108 Streptococcus milleri 13/05/2013 Genital swab
QE109 Streptococcus Group G 13/05/2013 Genital swab high vaginal
QE110 Streptococcus Group A 13/05/2013 Wound swab
QE111 Streptococcus Group A 15/05/2013 Wound swab ankle
QE112 Streptococcus Group G 17/05/2013 Ulcer swab ankle
QE113 Enterococcus sp. 08/01/2013 Faeces
QE114 Enterococcus sp. 12/12/2012 Faeces
QE115 Enterococcus sp. 06/12/2012 Faeces
QE116 Enterococcus sp. 17/03/2013 Faeces
QE117 Enterococcus sp. 06/02/2013 Faeces
QE118 Enterococcus sp. 19/01/2013 Faeces
QE119 Enterococcus sp. 07/01/2013 Faeces
QE120 Enterococcus sp. 12/12/2012 Faeces
QE121 Enterococcus sp. 16/03/2013 Faeces
QE122 Enterococcus faecium 27/09/2012 Mid stream urine
QE123 Enterococcus sp. 30/01/2013 Faeces
QE124 Enterococcus sp. 17/02/2013 Faeces
QE125 Enterococcus sp. 02/11/2012 Faeces
QE126 Enterococcus sp. 13/05/2013 Faeces
QE127 Enterococcus sp. 18/05/2013 Faeces
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Number Species Date collected Site collected
QE128 Enterococcus sp. 03/04/2013 Faeces
QE129 Enterococcus sp. 03/04/2013 Faeces
QE130 Enterococcus sp. 11/05/2013 Faeces
QE131 Enterococcus sp. 13/05/2013 Faeces
QE132 Enterococcus sp. 06/05/2013 Faeces
QE133 Enterococcus sp. 06/05/2013 Faeces
QE134 Enterococcus sp. 04/02/2013 Faeces
QE135 Enterococcus sp. 22/03/2013 Faeces
QE136 Enterococcus sp. 25/09/2012 Faeces
4.2.3 Antibiotic Susceptibility Testing
The 136 isolates were received from Queen Elizabeth hospital (Table 4.4)
in Norfolk were first screened for resistance to the antibiotics tetracycline,
erythromycin and vancomycin at a concentration of 4µg/ml, as this con-
centration is higher than the breakpoint required by the British Society for
Antimicrobial Chemotherapy (BSAC) for the bacteria to be considered clin-
ically resistant (Table 4.6). Those isolates that were resistant to any of these
antibiotics were taken forward for further analysis.
4.2.4 Determination of Species
Information regarding the species of bacteria was provided by the Queen
Elizabeth hospital upon receipt of the isolates. However this information
was obtained using biochemical speciation methods that are known to be less
accurate than molecular methods. Therefore the isolates that were identified
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as resistant were speciated by amplifying the 16S gene by PCR,(primers: 27F
AGRGTTYGATYMTGGCTCAG, 1391R GACGGGCGGTGWGTRCA, 94oC
for 5 minutes, then 34 cycles of 94oC for 30 seconds, 52oC for 30 minutes,
72oC for 30 seconds followed by a final extension of 72oC for 5 minutes) then
sequencing this gene and comparing it to the BLAST nucleotide database.
Those isolates that were identified as belonging to the genus Streptococcus
were also identified via sequence analysis of the superoxide dismutase A gene
(sodA), as this gene provides more accurate species data than 16S in the
case of Streptococcus (Poyart et al., 1997). The species data is represented
in Table 4.6.
4.2.5 Gene Detection
Polymerase chain reaction (PCR) was employed to detect the presence of
genes linked to antibiotic resistance or mobile genetic elements. PCRs for
the following genes were carried out: tetM, tetO, tetK, tetL, tet32, ermA,
ermB, ermC, mefA, mphA, ereA, ereB. Representative isolates from positive
PCRs were sequenced and the sequence data subsequently compared to the
NCBI database in order to confirm that the PCR reactions have amplified
the correct sequence.
4.3 Results
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4.3.1.1 Anatomical Sites and Antibiotic Resistance
Antibiotic resistance testing revealed that 25 isolates (18%) were resistant to
tetracycline, 19 isolates (14%) were resistant to erythromycin and 21 isolates
(15%) were resistant to vancomycin.
Strains that displayed resistance to the antibiotics that they were tested
against in this study were most commonly isolated from the legs (n = 11),
vagina (n = 5) and faeces (n = 20). The resistant bacteria that were iso-
lated from the legs included a diverse range in bacterial species composed of
Streptococcus pyogenes, Corynebacterium striatum, Streptococcus dysgalac-
tiae, Staphylococcus simulans and Staphylococcus aureus.
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Table 4.7: Distribution of species by anatomical site.
Penis Head Blood Sputum Nose Breast Leg Kidney
S.aureus 1 1 1 1 1 1 1 1
S. agalactiae Vaginal PEG Site Ear Blood
3 1 1 3
S. dysgalactiae Pressure sore Leg Ankle
1 3 1
S. pyogenes Leg Wound Ankle Vaginal
1 1 1 1
C. striatum Calf Leg Ankle
1 1 1
S. hominis Throat Vaginal
1 1
S. simulans Ankle
1
4.3.2.1 Confirmation of PCR Results via Sequencing
Sanger sequencing was performed on PCR product from representative iso-
lates that were positive for the different genes in order to confirm that the
PCR results were genuine. The isolates selected as representatives and the
DNA sequencing data are shown in Table 4.8. Following sequencing, these
isolates were used as positive controls in PCRs specific for their respective
genes. No template controls (NTCs) were used as negative controls.
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Table 4.8: Sanger sequencing results of PCR product from representative isolates
where amplification had taken place using PCR primers that are specific for re-
sistance genes. These results confirm that PCR product amplified was the target
gene. QC refers to query cover, ID refers to the percentage identity match of the
sequence to the closest homologue in the NCBI database.
ID Closest Homologue QC% ID%
QE16 ermA 100 99
QE40 ermB 99 100
QE25 ermC 100 98
QE16 int and xis 100 100
QE40 tetO 99 100
QE113 vanA 99 100
4.3.3 Distribution of genes
The int (integrase) and xis (excisionase) genes were detected in 11 isolates,
in 100 % of cases these isolates also contained antibiotic resistance genes
9 tetracycline (tetM ), 2 tetracycline and erythromycin, (tetM and ermA).
Phenotypic resistance was observed in 100 % of the isolates where resistance
determinants were detected.
tetM was the most abundant tetracycline resistance gene, detected in 2 (25%)
of Staphylococcus aureus isolates, 1 (33%) Corynebacterium striatum isolate,
7 (87.5%) Streptococcus agalactiae isolates 5 (100%) Streptococcus dysgalac-
tiae and 4 (100%) Streptococcus pyogenes isolates.
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4.3.4 Tetracycline Resistance Genes
4.3.4.1 tetM
The gene tetM was the most commonly observed tetracycline resistance gene
that was observed in the tetracycline resistant isolates (76%). This gene was
observed in a wide variety of species. In 84% of the isolates containing tetM,
the int and xis genes were also identified, revealing the possibility that in
these cases, the tetM gene may have been acquired on an element that is
related to Tn916.
4.3.4.2 tetO
tetO was observed in a single isolate of Streptococcus dysgalactiae that was
isolated from a vaginal swab. This isolate tested positive for both tetO and
tetM. The MIC for this isolate was 32µg/ml, as this isolate contains both
tetO and tetM it is not possible to determine from the MIC which (if not
both) of these tetracycline resistance genes are active and responsible for
conferring resistance to tetracycline in the case of this isolate.
4.3.5 Speciation
4.3.5.1 Accuracy of Biochemical Speciation Test vs 16S or sodA
Sequencing
The pathology laboratory at the Queen Elizabeth hospital carried out bio-
chemical testing in order to determine the species of the strains that were
received. DNA sequencing of the 16S or sodA genes in the case of strepto-
cocci was carried out in order to verify any bacterial species data. The data
that was supplied regarding the biochemical testing has been compared with
the data obtained via DNA sequence analysis in order to determine the ac-
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curacy of the biochemical testing. Strains identified as S. aureus were agreed
by both the biochemical and molecular testing methods in 100% of the cases.
Group B Streptococci (Streptococcus agalactiae identification agreement was
achieved in 100% of the cases).
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4.3.6 MIC Data
Table 4.9: Minimum inhibitory concentrations of tetracycline and erythromycin
required to prevent growth of the bacterial isolates from wounds. The dashes in
this table refer to isolates that were sensitive to the antibiotic and displayed no
evidence of resistance.
ID Tetracycline (µg/ml) Erythromycin (µg/ml)
QE16 34 >256
QE25 - >256
QE28 64 >256
QE40 32 >256
QE41 4 -
QE42 - 8
QE45 16 -
QE47 - >256
QE48 16 -
QE49 32 >256
QE50 - >256
QE59 - 2
QE62 32 -
QE69 - >256
QE82 - >256
QE89 16 -
QE91 4 -
QE92 32 -
QE93 32 -
QE94 - >256
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ID Tetracycline (µg/ml) Erythromycin (µg/ml)
QE96 32 -
QE97 4 -
QE98 8 -
QE99 8 -
QE102 8 -
QE103 8 -
QE104a 4 >256
QE104b - 8
QE105 4 -
QE106 16 >256
QE107 8 -
QE110 4 -
QE111 4 -
4.3.7 Antibiotic Resistance Genes
The following antibiotic resistance genes were identified via PCR ermA (n =
3) ermB (n = 2), ermC (n = 6). ermC was the most commonly observed
erythromycin resistance determinant, it was observed in Staphylococcus au-
reus (n = 5), Staphylococcus simulans (n = 1) and Streptococcus hominis
(n = 1). Erythromycin resistance determinants ermA and ermB were less
common, with ermA being observed in Staphylococcus aureus (n = 3) and
Steptococcus agalactiae.In the case of 6 erythromycin resistant isolates, all
of the erythromycin resistance genes that were tested for failed to amplify.
The PCR reactions were negative for the resistance genes tetK, tetL, tet32,
mphA, mefA, ermA, ermB. The species and resistance genes are presented in
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Table 4.10. A representative of each gene was analysed by Sanger sequenc-
ing (Table 4.8) and the sequence compared to the NCBI database in order
to confirm whether the PCR data was accurate. These representatives were
used as positive controls in the PCRs, NTCs were used as negative controls.
4.3.8 Evidence of Transposable Elements
As a preliminary test for the presence of mobile genetic elements, PCR was
carried out amplifying the integrase and excisionase genes that are are associ-
ated with a variety of different transposons, the data is shown on Table 4.10.
The integrase and excisionase genes were widespread amongst the isolates.
The int&xis PCR reaction was positive in isolates of Staphylococcus aureus
(n = 6), Staphylococcus aureus (n = 2), Streptococcus dysgalactiae (n = 5),
Streptococcus agalactiae (n = 8) and Streptococcus pyogenes (n = 2).
4.3.8.1 Integrase and Excisionase
The PCRs that were carried out amplifying the int and xis genes that were
originally detected on the conjugative transposon Tn916. The integrase and
excisionase enzymes are involved with the mobility of the element. The ex-
cisionase protein is encoded by the xis gene, the integrase protein is encoded
by the int gene. Integrase is a heterobivalent recombinase that is regulated
by excisionase.
Excisionase has a modest stimulating effect upon excision compared with
the λ,Xis from bacteriophage λ (Abbani et al., 2005). The integrase pro-
tein is able to bridge the core-type and DR2-type sites on the left arm of
the transposon. The binding of excisionase does not alter the stability of the
DR2-integrase-core bridges or the ability of integrase therefore the regulation
effect of excisionase on integrase is loose (Abbani et al., 2005).
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4.3.9 Species Detected
4.3.9.1 Staphylococcus hominis
S. hominis was only detected in two of the resistant wound isolates. This is
as expected, as this species is commensal only causing infection in individuals
who are immunocompromised. In both cases these isolates are resistant to
erythromycin and sensitive to tetracycline. MICs were lower in the case of
these two isolates than most of the other erythromycin resistant isolates. 50%
(n = 1) of the erythromycin resistant isolates contained the erythromycin re-
sistant determinant ermC, this determinant has been detected in this species
previously and is frequently present (Aslantas¸ et al., 2013).
4.3.9.2 Streptococcus agalactiae
Streptococcus agalactiae is a group B streptococci. This species is an oppor-
tunistic pathogen that is usually carried by asymptomatic individuals. Of
the strains that were received were identified as Group B streptococci, 100%
(n = 8) were resistant to tetracycline and 25% (n = 2) were resistant to
erythromycin. All tetracycline resistant S. agalactiae isolates contained the
determinant tetM which is consistent with the common occurrence of tetM
in this species according to the literature (Fischer et al., 2013), one of these
isolates also contained tetO. All erythromycin resistant isolates contained
ermB.These findings are consistent with other reports investigating tetra-
cycline and erythromycin resistance determinants as tetM, tetO and ermB
have all been frequently detected in S. agalactiae, the frequency of distri-
bution between tetM and tetO that has been observed in this study is also
consistent with previous reports where although both detected, tetM is far
more common (Dutra et al., 2014; Dogan et al., 2005; Gherardi et al., 2007;
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Bergal et al., 2015). The gene ermB is also a common resistance gene found
in S. agalactiae (Lee and Lai, 2015).
4.3.9.3 Streptococcus dysgalactiae
S. dysgalactiae is a group C streptococci. Of the strains received were iden-
tified as Group C streptococci,5 were resistant to tetracycline and 2 were
resistant to erythromycin. The determinant tetM was detected in 100% of
the tetracycline resistant isolates, tetM is a commonly observed resistance
gene in S. dysgalactiae (Abdelsalam et al., 2013; Hashikawa et al., 2004;
Burdett et al., 1982). The determinant that was responsible for conferring
resistance to erythromycin in two of the isolates was not detected.
4.3.9.4 Streptococcus pyogenes
S. pyogenes is a pathogenic species of bacteria that is the cause of Group A
streptococcal infections. S. pyogenes may cause a variety of different disease
conditions, these range from skin and throat infections to systemic diseases
such as endocarditis or meningitis. In this study, S. pyogenes / Group A
Streptococci was identified in 4 isolates, all 4 of which were resistant to
tetracycline and 1 of which were resistant to erythromycin. Isolates showing
phenotypic resistance to tetracycline all tested positive for the resistance
determinant tetM, a gene that frequently present in tetracycline resistant S.
pyogenes (Perez-Trallero et al., 2007).
4.3.9.5 Enterococcus faecalis
The species E. faecalis was originally classified as Streptococcus faecalis or
“Group D Streptococci”. All but two of the isolates were observed to be
resistant to vancomycin (Results in Table 4.6 the negative control B. subtilis
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CU2189 was used, no positive control was available however the presence of
the vanA gene was confirmed by DNA sequencing of product from QE113
(Table 4.8)). These because bacteria were not screened for resistance to tetra-
cycline or erythromycin because resistance to these antibiotics is so common
that they are rarely considered for treatment of enterococcal infections. En-
terococci resistant to vancomycin first emerged in the mid 1980’s.
4.3.9.6 Staphylococcus aureus
The following QE isolates were identified as being S. aureus : QE16, QE25,
QE28, QE47, QE69 and QE82 (Table 4.6). These isolates were screened for
methicillin resistance in accordance with the British Society for Antimicro-
bial Chemotherapy (BSAC) guidelines by being cultured on ISO-sensitest
agar containing 4µg/ml cefoxitin. Isolates QE16, QE28, QE47 and QE69
grew indicating that they were methicillin resistant (Table 4.11). The re-
sistant isolates were tested for the presence of the mecA gene via PCR as-
sociated with the staphylococcal chromosomal cassette SCCmec. All four
isolates tested positive for mecA suggesting that these isolates may be carry-
ing SCCmec however this cannot be confirmed due to the lack of a positive
control (Table 4.11).
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Table 4.11: Cefoxitin susceptibility screening and SCCmec PCR results. Bacillus
subtlis strain CU2189 and a no template control (NTC) were used as negative
controls. A positive control was not available.
ID Growth on Cefoxitin (4µg/ml) SCCmec PCR
QE16 X positive
QE28 X positive
QE47 X positive
QE69 X positive
QE82 − negative
CU2189 − negative
NTC − negative
4.4 Development of a PCR Based Method
Facilitating the Detection of Tn916
A method allowing the rapid screening of the transposon Tn916 in bacterial
isolates has been developed. This method is based upon two PCR reactions,
that amplify two regions encompassing the whole transposon, the amplicon
was then digested using the restriction enzyme HincII, run on an 0.75%
agarose gel for 1 hour and the resulting digestion profile was then used to
identify whether or not the transposon is Tn916. The control strains were
CU2189 and BS34A, information regarding these controls is shown on Table
4.13.
Initially, the PCR was performed using two primers, one specific for each
end of Tn916 using the primers (LongA-01F GGACTTATCACACTTTAT-
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CAAGG, LongB-PW01R CTGTAGGAAGATACTTCACG) provided by Dr
Phillip Warburton, using reaction conditions of 95oC for 4 minutes, followed
by 30 cycles of 95oC for 30 seconds, 53oC for 30 seconds 68oC for 15 min-
utes followed by a final extension of 68oC for 15 minutes. LongAmp Taq
(Promega, USA), a taq polymerase that is specialised for the amplification
of long DNA fragments was used. The amplification was unsuccessful, leading
to the further attempt to amplify the Tn916 transposon (Fig. 4.1) by divid-
ing the transposon into two target amplicons (Fig. 4.2). The PCR on the
first section was performed using the primers (LongA-01F GGACTTATCA-
CACTTTATCAAGG, LongA-CT25R AAACAGAAGCAGTGAGAAGA) and
the PCR on the second section was performed using the primers LongB-
CTn9824F GAAAACTTTAGTGATTGGTGG, LongB-PW01R CTGTAG-
GAAGATACTTCACG) provided by Dr Phillip Warburton. The following
reaction conditions were used: 95oC for 4 minutes, followed by 30 cycles of
95oC for 30 seconds, 50oC for 30 seconds, 68oC for 10 minutes, with a final
extension of 68oC for 10 minutes. These conditions proved effective (Fig.
4.3), a single strong band in the positive control BS34A (details regarding
this strain shown on Table 4.13) was produced from the Long A primers, how-
ever the reaction using the Long B primers produced a “smear” suggesting
the presence of non specific binding, and the possibility that the annealing
temperature tested may be too low for these primers. To investigate this, a
temperature gradient PCR was performed.
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Figure 4.1: Schematic diagram of Tn916 detailing the two sections that were
amplified via PCR to produce two separate amplicons that cover the majority of
the transposons structure. Amplicon A ranges covers positions 38 to 9844 and
Amplicon B covers positions 9824 to 17947. The red rectangle represents the area
covered by primer set ‘A’ and the blue rectangle represents the area covered by
primer set ‘B’. The green circles show the restriction target sites for HincII, these
sites are detailed in Table 4.12
Table 4.12: Fragment sizes of each amplicon following digestion with HincII and
the location of where upon the amplicon that each fragment originated from.
Amplicon A Amplicon B
Start End Length Start End Length
1 916 916 1 202 202
917 2127 1211 203 5113 4911
2128 2589 462 5114 8124 3011
2590 5364 1775
4365 9807 5443
4.4.1 Temperature Gradient PCR
The first temperature gradient PCR was performed between a temperature
range of 51oC and 54.5oC on both sets of primers however significant non
specific binding was still observed within the reaction using the “Long B”
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Figure 4.2: “Long A” and “Long B” PCR reactions run at 95oC for 4 minutes,
followed by 30 cycles of 95oC for 30 seconds, 50oC for 30 seconds, 68oC for 10
minutes, with a final extension of 68oC for 10 minutes. Information regarding the
control strains BS34A and CU2189 is presented in Appendix .1
0.75% agarose gel run at 100V for 1 hour, lanes from left to right:
1) Hyperladder 1kb,
2) BS34A with primer set A (Tn916 positive)
3) CU2189 with primer set A (Tn916 negative)
4) No template control with primer set A
5) BS34A with primer set B (Tn916 positive)
6) CU2189 with primer set B (Tn916 negative)
7) No template control with primer set B
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primers (Fig. 4.3). To address this two approaches were attempted, another
heat gradient was carried out only using the “Long B” primers, the tem-
perature range of the gradient was expanded to run from 51oC to 58oC, in
addition to this, reactions were carried out using half the primer concentra-
tion (5µl). An annealing temperature of 58oC and primers at a concentration
of 10µM (Fig. 4.4).
4.4.2 Restriction Digest with HincII
A restriction digest was carried out on section A and section B of Tn916,
with HincII (Fig 4.5).
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Figure 4.3: Primer sets “A” and “B” run on a temperature gradient PCR. The tem-
perature gradient travels from left to right and ranges between 51oC and 54.5oC.
0.75% agarose gel run at 100V for 1 hour, lanes from left to right:
1) Hyperladder 1kb,
2) BS34A with primer set A (Tn916 positive)
3) CU2189 with primer set A (Tn916 negative)
4) BS34A with primer set B (Tn916 positive)
5) CU2189 with primer set B (Tn916 negative)
6) BS34A with primer set A (Tn916 positive)
7) CU2189 with primer set A (Tn916 negative)
8) BS34A with primer set B (Tn916 positive)
9) CU2189 with primer set B (Tn916 negative)
10) BS34A with primer set A (Tn916 positive)
11) CU2189 with primer set B (Tn916 negative)
12) BS34A with primer set B (Tn916 positive)
13) CU2189 with primer set B (Tn916 negative)
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Figure 4.4: Primer sets “A” and “B” run on a temperature gradient PCR. The
temperature gradient travels from left to right and ranges between 51oC to 58oC.
0.75% agarose gel run at 100V for 1 hour, lanes from left to right:
1) Hyperladder 1kb,
2) CU2189 10µM primer, ≈51oC (Tn916 negative)
3) BS34A 10µM primer, ≈51oC (Tn916 positive)
4) CU2189 5µM primer, ≈51oC (Tn916 negative)
5) BS34A 5µM primer, ≈51oC (Tn916 positive)
6) CU2189 10µM primer ≈55oC (Tn916 negative)
7) BS34A 10µM primer ≈55oC (Tn916 positive)
8) CU2189 5µM primer ≈55oC (Tn916 negative)
9) BS34A 5µM primer ≈55oC (Tn916 positive)
10) CU2189 10µM primer ≈58oC (Tn916 negative)
11) BS34A 10µM primer ≈58oC (Tn916 positive)
12) CU2189 5µM primer ≈58oC (Tn916 negative)
13) BS34A 5µM primer ≈58oC (Tn916 positive)
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Figure 4.5: HincII digestion carried out in duplicate on the two amplicons from,
they were ran on 0.75% agarose gel, run for 1 hour at 100V. Lanes from left to
right,
1) Hyperladder 1kb
2) Amplicon A from strain BS34A digested with HincII
3) Amplicon B from strain BS34A digested with HincII
4) Amplicon A from strain BS34A digested with HincII
5) Amplicon B from strain BS34A digested with HincII
6) Amplicon A no enzyme (negative control)
7) Amplicon B no enzyme (negative control)
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Table 4.13: The control strains, CU2189 is a laboratory generated strain of Bacillus
subtilis that does not contain Tn916, BS34A is derived from CU2189 and contains
a single copy of Tn916. CU2189 was used as a negative control and BS34A was
used as a positive control.
Strain Species Transposon content Reference
CU2189 B. subtilis None (Christie et al., 1987)
BS34A B. subtilis Tn916 (Roberts et al., 2003)
4.4.3 Long PCR and HincII Digest on tetM Positive
Isolate DNA
The PCR technique described above was employed on the isolates where the
tetracycline resistance determinant tetM had been detected (Table 4.10).
The isolates that had a restriction profile that matched Tn916 were QE16,
QE28, QE45. Isolates QE107, QE110 and QE111 matched section B of
Tn916 but not section A suggesting that the latter three isolates may contain
an element that is related to Tn916 (Figure 4.6).
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Figure 4.6: Digest of long PCR amplicons from QE isolates with HincII. Lanes
from left to right:
1) Hyperladder 1kb 11) QE99
2) QE16 12) QE102
3) QE28 13) QE103
4) QE40 14) QE104A
5) QE45 15) QE107
6) QE48 16) QE110
7) QE89 17) QE111
8) QE91 18) CU2189 (negative control)
9) QE97 19) BS34A (positive control)
10) QE98
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4.5 Investigation into tetW gene in Corynebac-
terium striatum
4.5.1 tetW in Corynebacterium striatum
Two Corynebacterium striatum isolates, tested positive using degenerate primers
that amplify multiple genes that encode ribosomal protection proteins (RPP),
and negative using the PCR primers for the common antibiotic resistance
gene tetM. Sanger sequence analysis of the PCR product that was produced
using the RPP primers revealed that the tetracycline resistance gene that the
Corynebacterium striatum isolates were carrying was tetW. There is only one
such case in the literature of this gene being found in this species of bacteria.
However tetracycline resistance in Corynebacterium striatum itself is not a
new observation. Tetracycline resistance determinants previously reported
in this species include tetM (Roberts et al., 1992) and the plasmid mediated
tetAB (Tauch et al., 1999).
Previous research has investigated the association between tetW and mo-
bile genetic elements, and it was revealed that this resistance determinant
was harboured by TnB1230 originally from Butyrivbrio fibrisolvens (Melville
et al., 2014). The flanking regions of tetW from Corynebacterium striatum in
this study do not match TnB1230 (Fig. 4.7, 4.8) suggesting that C. striatum
acquired this gene via different means. ClustalW analysis was carried out
comparing TnB1230 with Tn5253, Tn1311 and the plasmid pRAB11 and
no matching areas were found. There is currently no record in the literature
of tetW being associated with the Tn5253 family.
With this gene having only been observed in C. striatum on one previous
occasion within China, and the regions that immediately flank this gene con-
taining a replication protein that originates from S. pneumoniae or S. aureus.
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This gene suggests that the section of DNA next to tetW was originally from
either S. pneumoniae or S.aureus. Presently there is no record of tetW being
detected in S. pneumoniae however this gene has been detected in S. aureus
(Spanu et al., 2011).
Figure 4.7: Schematic of TnB1230, adapted from (Melville et al., 2014)
Figure 4.8: Diagram representing the DNA amplified via inverse PCR in this study,
the black line represents noncoding DNA, the red section represents an ORF, of
which the translated amino acid sequence matches a replication protein from S.
pneumoniae (Acc. WP 079118347.1).
Figure 4.9: The blue represents the ORF identified on the common region of
DNA between pRAB11 and Tn5253, the red represents the ORF identified on the
segment of DNA flanking tetW that was amplified via inverse PCR.
4.5.1.1 Tn1311
Tn1311 was first characterised in 2011 (Mingoia et al., 2011). This trans-
poson belongs to the Tn5253 family. This family of transposons are large
(>50 kb). The prototype transposon for this family Tn5253 is composed of
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two smaller independent conjugative transposons Tn5251 (almost identical
to Tn916 and Tn5252. Analysis revealed that the flanking regions matched
with the conjugative transposons Tn5253 and Tn1311 originally from Strep-
tococcus pneumoniae as well as the plasmid pRAB11, these regions are shown
on Fig. 4.10).
4.5.1.2 Tn5253 and pRAB11
ClustalW analysis (Bioedit) of Tn5253 and pRAB11 revealed that there is a
14560bp region that is common to Tn5253 and pRAB11, with the exception
of a T−G substitution at position 53808 on Tn5253. Analysis with Artemis
revealed two potential open reading frames (ORFs). Nucleotide BLAST anal-
ysis showed that these two potential ORFs revealed a variety of homologues,
mostly originating from Streptococcus and Staphylococcus species, these are
shown in Table 4.14. A schematic of Tn5253 is shown in Fig.4.11.
An ORF was detected upon the region of DNA found in both Tn5253 and
pRAB11 at position 177 to 1121. The closest homologue to the translated
protein of this ORF is a replication protein originating from S. aureus (Acc.
WP 012386790.1) (99/100). The sequence flanking the tetW gene in C. stria-
tum contained an ORF that when compared to the NCBI database, matched
(querey cover 100%/ ID 100%) a partial replication protein from S. pneu-
moniae (Acc. WP 079118347.1). The sequence of DNA amplified from the
regions flanking tetW in C. striatum was 720bp in length, and contained one
ORF located from position 718 to 371. When compared against the NCBI
database, the closest homologue to this ORF (matching 100% query cover
and 100% ID) was a partial replication protein originating from S. pneumo-
niae, however this amino acid sequence also matches part of the replication
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protein translated from the ORF present on the region of DNA common to
Tn5253 and pRAB11 (Fig. 4.9).
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Table 4.14: Closest matches on the BLAST nucleotide database to the two poten-
tial open reading frames that were identified using Artemis on the section of DNA
common to both Tn5253 and pRAB11.
Region 281− 1 QC% ID% Accession number
pRAB11 100 100 JN635500.1
pRIT23 100 99 LC257602.1
pRIT22 100 99 LC257599.1
S. pneumoniae strain Hu15 100 99 CP020551.1
S. pneumoniae strain Hu17 100 99 CP020549.1
S. aureus knockdown vector pSD1 100 99 KX685167.1
S. mitis strain SVGS 061 100 99 CP014326.1
pRIT21 100 99 LC121520.1
Region 117 − 1121 QC% ID% Accession number
S. pneumoniae strain Hu15 genome 100 100 CP020551.1
S. pneumoniae strain Hu17 genome 100 100 CP020549.1
S. aureus strain Gv88 plasmid pGv88 100 100 CP012017.1
S. aureus strain Gv51 pGv51 100 100 CP012016.1
S. aureus replication protein 100 100 AB982227.1
S. pneumoniae ICE6BST90 100 100 HG799499.1
S. pneumoniae ICESpcIc1 100 100 HG799494.1
S. aureus plasmid pBmb9393 100 100 CP005289.1
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4.6 Discussion
4.6.1 The Antibiotic Resistance Genes that were De-
tected
4.6.1.1 Erythromycin
Over the course of this study, the most commonly observed erythromycin
resistance determinant was ermC, followed by ermA and ermB. These genes
are rRNA methylase enzymes. These rRNA methylases confer resistance
to erythromycin via the methylation of the 23S ribosomal rRNA. Of the
erythromycin resistance genes that were identified belonged to the rRNA
methylase group. The PCRs for genes that confer resistance to erythromycin
via alternative mechanisms (eﬄux, the production of inactivating enzymes)
were negative in all cases. There were erythromycin resistant isolates that
did not amplify with any of the primers that were tested.
4.6.1.2 Tetracycline
tetM was the most commonly detected tetracycline resistance gene that was
detected in these isolates followed by tetO. These findings are consistent
with the published literature whereby tetM is the most frequently occurring
tetracycline resistance gene, and it is often found within tetracycline resistant
isolates that have been obtained from wounds (Emaneini et al., 2013; Schmitz
et al., 2001).
4.6.1.3 Vancomycin
Throughout this study, vancomycin resistance was only observed in entero-
cocci. All vancomycin resistant enterococci tested positive for the presence
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Figure 4.11: Diagram showing the structure of Tn5253 from (Iannelli et al., 2013)
of the vanA gene.
4.6.2 Species Identified Compared with the Literature
4.6.2.1 Staphylococcus aureus
In total, 47 isolates of S. aureus were received. Of the resistant isolates, 7
(15%) were identified as resistant to tetracycline or erythromycin.
The bacteria S. aureus was fist isolated from a leg abscess and identified in
the 1880’s (Ogston, 1984). This species is typically resident upon the skin
and around the nose and respiratory tract of healthy individuals. S. aureus is
a clinically important species of bacteria, as while it is not pathogenic under
normal conditions, it is an opportunistic pathogen that can cause soft skin
infections leading to abscess development, respiratory infections and food
poisoning if it enters the digestive tract.
The most frequently detected erythromycin resistant determinants in the S.
aureus isolates were ermA (37.5%) and ermC (62.5%), according to the lit-
erature these genes are commonly found to confer resistance in erythromycin
resistant S. aureus (Shahsavan et al., 2012).
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tetM was the only tetracycline resistant determinant that was detected in
S. aureus, the presence of this gene in tetracycline resistant S. aureus is not
surprising as this gene has been frequently detected in tetracycline resistant
S. aureus in previous studies (Emaneini et al., 2013).
4.6.2.2 Staphylococcus hominis
S. hominis was only identified in two of the resistant wound isolates. This
lower incidence is as expected, as this species is usually commensal predom-
inantly causing infection in individuals who are immunocompromised. In
both cases these isolates are resistant to erythromycin and sensitive to tetra-
cycline. MICs were lower in the case of these two isolates than most of the
other erythromycin resistant isolates. 50% (n = 1) of the erythromycin re-
sistant isolates contained the erythromycin resistant determinant ermC, this
determinant has been detected in this species previously and is frequently
present (Aslantas¸ et al., 2013). In recent years the emergence of S. hominis
infections has been noted in nosocomial infections (Voineagu et al., 2013),
nosocomial infections involving S. hominis appear most often in patients who
have invasive treatment, such as a catheter inserted (Doneli and Francolini,
2013) or surgery (Kleeff et al., 2015). In the case of this study, one S. ho-
minis isolate was taken from a vaginal swab and the other from the throat,
though this species is not often detected at these sites it has previously been
observed causing infection at both the vagina (Hoist et al., 1987) and the
throat (Xiao et al., 2012). While S. hominis may usually be associated with
immunocompromised patients, it has been observed as the cause of serious
infection in immunocompetent individuals, for example an apparently im-
munocompetent female who developed mastitis where only S. hominis was
detected within the aspirate (Datta et al., 2015).
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4.6.2.3 Streptococcus spp.
The streptococcal species detected were either opportunistic pathogens in
the cases of S. agalactiae and S. dysgalactiae or pathogenic (S. pyogenes)
therefore the presence of these species in wound sites is not unusual. The
detection of S. agalactiae was predominantly in blood culture and vaginal
swabs, this is consistent with previous reports where there have been periodic
reports of S. agalactiae sepsis (Lerner et al., 1977) in some cases in patients
with no risk factors (Warner et al., 2016). Vaginal infections caused by
S. agalactiae are observed (Maniatis et al., 1996) S. agalactiae is still not
uniformly acknowledged as a vaginal pathogen in the literature (Savini et al.,
2013), the findings of this study add further evidence supporting the case
that S. agalactiae is a vaginal pathogen. Tetracycline resistance is common
in this species, most frequently conferred by tetM (Fischer et al., 2013), the
results generated by this study are consistent with the literature as tetM is
present in all tetracycline resistant isolates of S. agalactiae. The determinant
tetM is also commonly observed in S. dysgalactiae, and this determinant
was detected in all S. dysgalactiae isolates. S. dysgalactiae and S. pyogenes
were isolated from wounds and blisters, these species have commonly been
reported as the causes of such infections (Brandt and Spellerberg, 2009). As
with the previous streptococcal species mentioned, tetM has been reported
previously and its detection amongst all tetracycline resistant S. pyogenes
isolates is consistent with reports in the literature (Soriano et al., 2014).
4.7 Conclusion
The most frequently detected tetracycline resistance gene was tetM, this gene
was present in a diverse range of unrelated bacterial species, it was also often
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associated with the genes int and tn which suggests that the gene may be
located upon a transposable element belonging to the Tn916 family.
The method of detecting Tn916 by a two stage PCR followed by the analysis
of a profile produced by restriction digest appears to be an effective method
for the cheap and efficient detection of this element. There is a potential for
this method to be developed further to include other elements allowing for an
inexpensive way to screen for the presence of different elements which could
perhaps be a useful tool for screening bacterial isolates for common elements
to maintain a surveillance detailing the frequency of these elements, and how
they may shift over time. The close similarity between the simulated restric-
tion digest with the actual profile that was generated with HincII indicates
that should the development of such a database of profiles be undertaken,
it may be useful to first generate carry out such simulations for a variety
of different restriction enzymes in order to generate profiles that sufficiently
differ between different related elements therefore allowing distinctions to be
made with a reduced risk of error.
The detection of a phenotypically active tetW in Corynebacterium striatum
for the first time outside of China suggests that this gene is moving between
species, whether tetW is located upon a mobile element is uncertain, as anal-
ysis of the DNA regions that flank the gene did match known mobile elements
such as the Tn5253 family and pRAB11, it is not possible to determine ex-
actly what element this gene is located upon, only that it is possibly located
upon an element that belongs to the Tn5253 family. As there is currently no
record of tetW being associated with the Tn5253 family, it is possible that
this gene is being harboured by a transposon belonging to this family that
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is yet to be characterised. That the flanking region contained part of a gene
that encodes a replication protein originating from Streptococcus pneumoniae
suggests that the gene may have originated in this species.To date, there has
been no reports of tetW in S. pneumoniae.
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Chapter 5
Discussion
5.1 Difference Between the Sample Sources
The samples that were used in this study were sourced from two different ar-
eas, one aspect focusing upon the antibiotic resistance genes and their genetic
support in the oral cavity of healthy volunteers and the other investigating
bacteria that have been isolated from swabs of wounds where there may be
infection present. The reason for doing this was to assess the difference be-
tween the resistant species that are present as well as the types of antibiotic
resistance gene and mobile elements.
5.1.1 Antibiotic Resistance
Antibiotic resistance to tetracycline and erythromycin was widely detected
in both isolates that were cultured from saliva and those that were cultured
from wounds. The resistance genes that were discovered in the isolates from
wounds have all been previously reported in their respective species as shown
on Table 5.1.
PCR analysis revealed that the genes responsible for resistance in the isolates
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from wounds were often also present in the metagenomic DNA extracted from
saliva. For example, tetM was the most common resistance gene detected in
the wound isolates, this gene was also detected in almost all of the metage-
nomic DNA, these observations are consistent with literature reports as tetM
is frequently detected.
The distribution of erythromycin genes however seems to be different. The
gene ermB was detected in every metagenomic saliva sample indicating that
it is abundant in the resistome in the absence of selection pressure. However
despite this ermB was only detected in ≈ 10% of the erythromycin resistant
isolates that were obtained from the wound cultures. However other studies
have previously reported ermB in each of the erythromycin resistant isolates.
5.2 Tn916 -like Elements
Evidence suggesting the presence of elements that belong to the Tn916 family
was detected in both the isolates from wounds and the saliva samples. The
int and xis genes were present in all of the metagenomic DNA samples that
were taken from saliva. These findings are consistent with reports that the
Tn916 family are widely disseminated.
The presence of int from Tn916 in all of the metagenomic DNA samples
taken from saliva are also consistent with previous reports demonstrating
that this gene is ubiquitous in the oral metagenome (Seville et al., 2009).
5.3 The Role of Plasmids
The TRACA section of this study detected plasmids from the saliva samples
from healthy individuals indicating the presence of a plasmid population har-
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bouring antibiotic resistance genes in the absence of antimicrobial selection
pressures. The antibiotic resistance genes that were detected conferred re-
sistance to β-lactam antibiotics and aminoglycosides. Therefore the findings
are clinically relevant as β-lactam antibiotics are frequently prescribed as the
first course of antimicrobial treatment following an infection.
5.4 The Resistome
The results generated by this study add to the body of evidence concerning
the resistance reservoir of antibiotic resistance genes. The genes that were
detected were common causes of antimicrobial resistance such as tetM and
ermB.
5.5 Targets for Antimicrobial Therapy
All of the saliva samples that were taken showed evidence indicating the
presence of Tn916 -like elements within their metagenomic DNA in the form
of integrase and excisionase genes. That the Tn916 family of elements fre-
quently harbour antibiotic resistance genes that confer resistance to a range
of unrelated antibiotics, their ubiquitous presence within the oral cavity is a
cause for concern. This is furthered by that they often carry genes that con-
fer resistance to tetracycline such as tetM as tetracycline is frequently used
in the treatment of oral infections because it is able to penetrate further into
the gum than other classes of antibiotics. Therefore, these integrase and ex-
cisionase genes could be potential targets for therapy, for a compound that
inhibits either one of these genes could prevent the transposon, and therefore
its accessory genes such as tetM from transferring between different bacte-
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ria thereby limiting the problem of a reservoir of Tn916 -like elements in
the commensal flora as the ability of Tn916 -like elements to transfer to the
pathogenic bacteria would be reduced.
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Chapter 6
Conclusions
The metagenomic study investigating the prevalence of various antibiotic re-
sistance determinants in the oral cavity of healthy volunteers has highlighted
that there appears to be a general consensus in the antibiotic resistance genes
that comprise the oral resistome in the case of tetracycline and macrolide
antibiotics. The tetracycline resistance determinant tetM was frequently
detected in both the oral metagenome and the isolates that were cultured
from wounds highlighting the importance of this resistance determinant in
tetracycline therapy. In addition to this, evidence of the transposon Tn916
and related elements was frequently detected in both the saliva and wound
samples. In addition to the presence of elements that are related to Tn916,
there was no evidence for the presence of any elements that belong to the
Tn5397 -like family, suggesting that elements that are related to Tn916 are
more prevalent. Therefore in future research that may take place aiming to
prevent the transfer of mobile elements that contain resistance determinants,
the Tn916 family are a reasonable target.
The species that were identified in the wound isolates were not unusual, in
that they were mostly bacterial species that typically reside on the skin and
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have been previously associated with opportunistic nosocomial infections.
The earliest detection of tetW in C. striatium was observed in this study.
The isolates containing the gene were obtained in 2013, approximately two
years before the first and only report that exists to date. This detection as
well as the subsequent detection of tetW in Corynebacterium striatum sug-
gests that this gene has recently entered the species and may be on a possible
novel mobile element.
The TRACA technique was successfully employed in capturing plasmids res-
ident in the metagenomic DNA from saliva samples, some of which were
shown to contain either one or two antibiotic resistance genes that were
demonstrated to be functional via MIC testing.
A method to quickly determine whether a bacterial isolate is carrying the
common transposon Tn916 was developed using a control isolate from the
species Bacillus subtilis that is known to contain Tn916. This method was
based upon amplifying two fragments of the Tn916 transposon over two PCR
reactions, performing a restriction digest on these fragments and analysing
the restriction profile. This proved to be a successful method and was sub-
sequently used to detect the presence of Tn916 in bacterial isolates taken
from wounds. This test could be further developed to generate known re-
striction profiles of other frequently occurring transposons. Such a technique
could be a useful tool both in research that is aiming to characterise novel
transposons by quickly screening out known common transposons as well as
research tracking the movement and distribution of transposable elements.
Antimicrobial resistance genes were detected in bacterial isolates taken from
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the oral cavity, as well as oral metagenomic DNA and isolates obtained from
wound swabs.The resistance genes were found to be functional.
The genes within the resistome that confer resistance to the antimicrobial
agents tetracycline and erythromycin were predominantly the same class,
these findings suggest that the resistance gene profiles are similar between
different individuals in the absence of disease.
6.1 Future Work
Based on the findings of this study, future work should involve research into
inhibiting the mechanisms that are involved in the mobilisation of trans-
posons, in particular those that belong to the Tn916 family due to their
frequent presence in individuals that have not been exposed to any antimicro-
bial therapy recently. The surveillance of the transposable elements should
continue in order to determine whether the elements contributing to the
maintenance of the resistome are changing and if so how they are changing.
Research into antibiotic resistance genes has shifted away from culture based
studies and towards a metagenomic approach. As technology advances, it
will be possible to sequence entire metagenomes therefore allowing for the
complete characterisation of the resistome of an environment. Without this
knowledge the ability to understand and characterise the origin and evolu-
tion of resistance determinants is limited (Martinez et al., 2015). Though this
may require the development of new approaches as the current methodology
for the identification of functional novel resistance genes is laborious and has
relatively low throughput (Schmieder and Edwards, 2012). The increase in
understanding of resistance determinants and mobile genetic elements will
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lead to insights into what triggers resistance transmission allowing for meth-
ods to control or potentially stop the transfer of resistance to be developed
(Roberts and Mullany, 2010).
The ongoing inappropriate prescription and misuse of antibiotics across medicine,
dentistry and agriculture will continue to contribute to the maintenance of
the antibiotic resistome resulting in difficulties in infection management and
therapeutic failure(Cope et al., 2014).
The rise in metagenomics is also likely to have an impact within the clinical
setting that goes beyond expanding knowledge in antimicrobial resistance
genes and their transfer (Sukumar et al., 2016). As large volumes of metage-
nomic sequence data are collected and made available it will be possible
to combine information regarding antimicrobial resistance genes, mobile ge-
netic elements, the composition of the microbial community and information
regarding metabolic pathways. Such analysis could be able to determine
whether and how these different factors are linked which may provide infor-
mation that is useful in reducing the selection for resistance (Sukumar et al.,
2016).
Until methods to inhibit the transfer of antibiotic resistance have been devel-
oped, the evolution towards antimicrobial resistance is unavoidable (Cour-
valin, 2016). It is also important to search for antivirulence drugs that inhibit
the pathogenic aspect of a microorganism without interfering with growth,
for as soon as growth is effected negatively then there is a selection pressure
that favours resistance (Courvalin, 2016).
Further research will allow for a more detailed understanding of the diver-
sity antimicrobial resistome and how it involved in the interactions between
commensal and pathogenic bacteria creating potential targets to control this
threat to public health.
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